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ABSTRACT
Choline oxidase from Arthrobacter globiformis is a flavin-dependent enzyme that
catalyzes the oxidation of choline to betaine aldehyde through two sequential hydride-transfer
steps. The study of this enzyme is of importance to the understanding of glycine betaine
biosynthesis found in pathogenic bacterial or economic relevant crop plants as a response to
temperature and salt stress in adverse environment. In this study, chemical modification of
choline oxidase using two irreversible inhibitors, tetranitromethane and phenylhydrazine, was
performed in order to gain insights into the active site structure of the enzyme. Choline oxidase
can also be inactivated irreversibly by freezing in 20 mM sodium phosphate and 20 mM sodium
pyrophosphate at pH 6 and -20 oC. The results showed that enzyme inactivation was due to a
localized conformational change associated with the ionization of a group in close proximity to
the flavin cofactor and led to a complete lost of catalytic activity.
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Chapter I
INTRODUCTION

1. Previous Studies of Choline Oxidase
1.1. Early studies. In 1937, an active form of choline oxidase was first isolated from rat
liver and kidney by Bernheim and Bernheim (1). The enzyme was capable of oxidizing choline
to betaine aldehyde with the uptake of one and two moles of oxygen at pH 6.7 and 7.8,
respectively. Subsequent work by Mann et al. reported a more detailed study on the same
enzyme (2). In that study, choline oxidase was considered as a typical dehydrogenase due to the
fact that rat liver extracts could reduce sodium ferricyanide rapidly under anaerobic conditions.
Kinetic studies showed evidence of this enzyme oxidizing choline and arsenocholine, and
oxygen uptake was observed corresponding to the formation of aldehyde species. The oxidation
of choline and arsenocholine by choline oxidase was inhibited by ammonium ions,
trimethylammonium ions, and betaine, suggesting that the trimethylammonium headgroup is
important for the binding of the ligand to the enzyme. Since choline dehydrogenase, in the
presence of choline and arsencholine, reduced cytochrome c at room temperature without the
help of enzyme cofactors, it was proposed that the choline oxidase system was composed of
choline dehydrogenase, cytochrome c, and cytochrome oxidase.
Choline oxidase from Arthrobacter globiformis was first purified by Ikuta et al. in 1977
(3). The purification procedure involved fractionations with ammonium sulfate and acetone,
followed by column chromatography using the anionic exchanger DEAE-cellulose and gel
filtration through a Sephadex G-200 column. The molecular mass of the isolated enzyme was
between 71 kDa and 83 kDa, as suggested by SDS-PAGE and gel filtration, respectively. UVvisible absorbance spectra of the enzyme showed maxima at 363 and 450 nm, consistent with the
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spectroscopic properties of a flavoenzyme. Kinetic data indicated that choline oxidase is capable
of utilizing both choline and betaine aldehyde as substrates to produce glycine betaine with Km
values of 1.2 mM and 8.7 mM, respectively. In addition, the enzymatic activity decreased
significantly when a number of substrate analogs were used, suggesting high substrate specificity
of the enzyme toward choline and betaine aldehyde. During the catalytic reaction of choline
oxidase, formation of hydrogen peroxide was detected as equivalent to the amount of oxygen
being consumed. Based on these data, the authors proposed a mechanism for the catalytic
reaction by choline oxidase, which involved the oxidation of choline to glycine betaine with
betaine aldehyde as the intermediate and molecular oxygen as the electron acceptor (Scheme 1.1)
(3, 4).

CH3
H3C N+
CH3

OH

H2O2
O2

CH3
H
H3C N+
CH3 O

H2O2
H2O, O2

CH3
O
H3C N+
CH3 O

Scheme 1.1. Reaction catalyzed by choline oxidase.
1.2. Prosthetic group of choline oxidase. In 1979, the prosthetic group of choline
oxidase from A. globiformis was studied in detail by digesting the enzyme into peptide fragments
with trypsin and chymotrypsin (5). The peptides were purified to reveal a fragment with a
typical UV-visible absorbance spectrum of a flavin. The flavin species in choline oxidase was
identified as FAD rather than FMN due to the fact that the flavin fluorescence intensity increased
by 2-fold upon release of AMP after the hydrolysis of the enzyme with nucleotide
pyrophosphatase. When the fluorescence excitation spectrum of the flavin peptide from choline
oxidase was compared with that of free riboflavin, a 25 nm hypsochromic shift of the 346 nm
peak to 361 nm was observed for the aminoacyl flavin. This suggested that the flavin cofactor
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was covalently attached to the enzyme via the 8α-methylene group of its isoalloxazine ring. In
order to determine whether the flavin is bound to N(1) or N(3) position of the histidyl ring,
sodium borohydride was used to reduce flavin. This was done because the N(1) isomer of
histidyl flavin could be reduced in the presence of borohydride, as followed by the quenching of
flavin fluorescence, whereas the N(3) isomer cannot be reduced (6). The purified flavin peptide
of choline oxidase was not reduced by sodium borohydride, suggesting that the flavin cofactor
was bound to the N(3) position of the histidine residue. A subsequent study by Ohta-Fukuyama
et. al. on choline oxidase from Alcaligens sp. confirmed 8α-[N(3)-histidyl]-FAD as the prosthetic
group of the enzyme, as suggested by the electrophoretic mobility of the hydrolysate of the
methylated histidylflavin (7). In that study, the flavin was bound to the enzyme with a 1:1 ratio
to give a spectrum with 358 nm and 453 nm maxima and a shoulder at 480 nm. The covalently
bound FAD in the native enzyme could be reduced with choline or betaine aldehyde under
anaerobic conditions and re-oxidized when exposed to air.
The spectroscopic properties of choline oxidase from Alcaligens sp. were investigated
thoroughly by Ohta et al. to provide an in depth understanding of the properties of the covalently
bound flavin (8). Upon reduction of the enzyme using dithionite or photo-irradiation in the
presence of EDTA, formation of flavin semiquinone was observed. This semiquinone was
catalytically inert towards organic substrate and oxygen.

The insensitivity of the flavin

semiquinone toward oxygen makes choline oxidase unique because such feature was not found
among other flavoenzymes. Choline oxidase could form a complex with glycine betaine, the
product of its catalytic reaction, with a dissociation constant of 17 mM at pH 7.5. When the
enzyme-product complex was reduced with dithionite or photo-irradiation under anaerobic
conditions, no semiquinone formation was detected. The reduced form of enzyme-product
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reacted with oxygen and reoxidized at two different rates: rapid and slow. The authors proposed
the formations of two different flavin species in the photoreaction of the enzyme-product
complex: a C4a adduct that reacted slowly with oxygen, and an N5 adduct that reacted quickly
with oxygen.
In a recent study, Rand et al. investigated the flavin linkage in choline oxidase from A.
globiformis (9). In that study, a purified histidylriboflavin was treated with NaBH4 in order to
distinguish between the N(1) and N(3) isomers. Treatment of NaBH4 stemmed from the fact that
flavin fluorescence of N(1)-histidylriboflavin can be irreversibly quenched upon reduction with
NaBH4, whereas N(3)-histidylriboflavin is unreactive toward NaBH4 (10).

N(1) and N(3)

isomers can also be distinguished by their stability in aqueous solution at room temperature: N(1)
is stable under these conditions but N(3) can be decomposed to 8-formylriboflavin (11). These
results, along with the pKa value from the pH-dependent fluorescence of the histidylriboflavin,
indicated an N(1)-linked flavin. The position of the histidine residue to which the flavin is
covalently bound was also examined by subjecting choline oxidase to tryptic cleavage. The
FAD-containing peptide was isolated using HPLC and analyzed with mass spectrometry. The
flavin-containing peptide was found to be the tripeptide His-Ala-Arg at position 87-89 based on
the nucleotide sequence of codA gene, which has been previously reported in Genbank
(accession number X84895) for choline oxidase from A. globiformis (12).

The authors

concluded that choline oxidase contains 8-[N(1)-histidyl]flavin at position 87 in its polypeptide
chain.1

Sequencing analysis of the cloned choline oxidase by our group in 2004 showed that the
nucleotide sequence of codA gene previously reported in Genbank in 2003 by Rand et al. (12)
contained seven flaws, resulting in a translated protein with significantly altered amino acid
sequence between position 298 and 410. Consequently, the results obtained based on that
sequence might not be accurate.

1

5
1.3. Biotechnological and medical applications. In the past decade, the biotechnological
and medical applications of choline oxidase have been studied extensively. This was motivated
by the finding that glycine betaine accumulated in the cytoplasm of cells as a resistance for
adverse environments with low and high temperature or hyperosmotic stress (13, 14). For plants
that do not synthesize glycine betaine, such as Arabidopsis thaliana, transformation of betainesynthesizing gene (codA gene from A. globiformis) into the plant cells significantly increased the
survival of the plants in high-salt soils (up to 300 mM NaCl) (15) or at freezing temperatures
(16). Over the years, many studies have been conducted in order to use the protective function
of glycine betaine to improve the economic production of crop plants, such as tomato (17), rice
(18, 19), and tobacco (20). In all cases, the presence of glycine betaine showed a significant
increase in cold and salt stress tolerance in growing plants. Accumulation of glycine betaine has
also been observed in human pathogens, such as Staphylocccus aureus (21), Pseudomonas
aeruginosa (22), and Listeria monocytogenes (23), in resistance to high osmolarities and
unsuitable thermal conditions. S. aureus is a bacterium commonly found on the skin of a healthy
person; it can cause illnesses ranging from minor skin infections to fatal diseases such as
pneumonia, meningitis, endocarditis and septicemia (13). L. monocytogenes is a food-born
pathogen that causes food poisoning and infections in digestive tracts (21, 23). P. aeruginosa
can cause a variety of systemic infections, such as dermatitis, bacteremia, urinary tract
infections, respiratory system infections, soft tissue infections, bone and joint infections, and
gastrointestinal infections. For these reasons, understanding the mechanism of the biosynthesis
of glycine betaine has the potential for the developments of therapeutic agents that can inhibit the
growth of these pathogens in the host tissue.
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1.4. Cloning and expression of choline oxidase. As the interest for understanding the
biosynthesis of glycine betaine in choline oxidase grew, large quantities of the enzyme were
needed for biophysical, mechanistic, and structural investigations.

In a recent study by our

group, the codA gene for choline oxidase was cloned from genomic DNA of A. globiformis strain
ATCC 8010 and expressed in the E. coli strain Rosetta(DE3)pLysS (24). The enzyme was
purified using DEAE-Sepharose column and characterized using mass spectrometry.

The

resulting enzyme contained a mixture of the anionic semiquinone and oxidized forms of FAD.
The oxidized form of choline oxidase was obtained after 24 h of dialysis at pH 6 and 4 oC. Gel
filtration and mass spectrometry indicated that the enzyme was a homodimer with covalently
bound flavin and a molecular mass of 120 kDa.

Enzyme assay with choline and betaine

aldehyde showed that the enzyme was active and used both as substrates. A newly amino acid
sequence was obtained for choline oxidase, showing a greater similarity between choline oxidase
and the members in GMC oxidoreductase superfamily than the sequence originally reported in
GeneBank (9). (See last paragraph in Section 1.2 for more detail)
1.5. Spectroscopic properties of choline oxidase. In another study, the spectroscopic
properties of recombinant choline oxidase with its cofactor in the oxidized and semiquinone
forms were characterized (25). The UV-visible absorbance spectrum of the oxidized enzyme
showed two typical flavin peaks at 359 and 452 nm, with an extinction coefficient at 452 nm of
11.4 mM-1 cm-1 at pH 8. This enzyme form emitted light at 530 nm when being excited at 452
nm. Upon incubation with dithionite under aerobic conditions, the peak at 452 nm in UV-visible
absorbance spectrum was bleached to give rise to a new spectrum with maxima at 372 and 495
nm. This spectrum remained unchanged after gel filtration was used to remove excess dithionite,
suggesting that choline oxidase stabilized the anionic semiquinone species of the flavin in the
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presence of oxygen. Consistent with this observation, the maxima of the flavin UV-visible
absorbance spectrum returned to 350 and 452 nm when the enzyme was unfolded with 4 M urea.
The circular dichroic spectrum of the enzyme-bound semiquinone showed a sharp negative peak
at 406 nm and a broad negative peak from 450 to 650 nm, which was in agreement with the
previously reported circular dichroic properties of enzyme-bound anionic flavin semiquinones
(7, 26). The anionic flavin semiquinone in choline oxidase was converted to its oxidized form
with kobs of 219 x 10-6 s-1 when the enzyme was incubated at pH 6 and 15 oC. The evidence for
this came from the bleaching of the 372 nm peak to give rise to a 452 nm peak in the UV-visible
absorbance spectrum. A similar bleaching of the 452 nm peak followed by an increase in
absorbance at 320 nm was also observed when the enzyme was treated with sodium sulfite, an
indication of the formation of a covalent N(5)-flavin adduct. The enzyme bound sulfite with a
Kd value of ~50 µM at pH 7 and 15 oC; such high affinity suggested the presence of a positive
charge near the N(1)C(2)=O locus of the flavin. UV-visible absorbance and steady state kinetics
were used to monitor the enzyme turnover with either choline or betaine aldehyde. The results
showed that the flavin semiquinone remained spectroscopically and kinetically insensitive to the
substrates and therefore did not participate in catalysis. The pH dependence of the kinetic
parameters was determined for both choline and oxygen using enzyme with oxidized flavin and
enzyme containing a mixture of oxidized and semiquinone flavins. The data indicated the
presence of a catalytic base with a pKa of ~ 7.5 that was required for the oxidation of the
substrate but not for the reduction of oxygen. In agreement with this observation, an ionizable
group with the same pKa value was required to be protonated for product inhibition, suggesting
that this ionizable group might belong to the same amino acid that acted as the catalytic base in
the oxidation of substrate.
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1.6. Kinetic properties of choline oxidase. The kinetic mechanism of commercially
available choline oxidase from A. globiformis was studied in detail using either choline or
betaine aldehyde as substrate (27). At pH 7, the steady state kinetic mechanism of the enzyme
was determined to be sequential. The reduced enzyme was found to react with oxygen before
the second oxidation step or before the release of the product. Based on the kinetic pattern of
1/rate versus 1/[O2], a Km value of ≤20 µM was estimated for betaine aldehyde as substrate,
consistent with betaine aldehyde preferentially partitioning forward to catalysis rather than
dissociating from the enzyme (28). This conclusion was further supported by the observation
that ≤10% betaine aldehyde was found in the reaction mixture under enzymatic turnover with
saturating concentrations of choline. The kcat for betaine aldehyde was two times higher than the
value observed with choline, suggesting that the oxidation of choline to the aldehyde
intermediate may be partially rate-limiting for catalysis. The results obtained from this study led
to a proposed mechanism for the reaction catalyzed by choline oxidase, which involved two
sequential flavin-linked hydride transfers from choline and the resulting betaine aldehyde
intermediate to molecular oxygen.
In a subsequent study, pH and deuterium kinetic isotope effects were used to examine the
oxidation of choline to betaine aldehyde (29). At atmospheric oxygen, the kcat and kcat/Km values
of choline oxidase increased with increasing pH to limiting values, suggesting the presence of a
catalytic base in catalysis. When choline was used as substrate in a pH-dependent study, an
apparent pKa of 7.5 was determined for the catalytic base. This pKa shifted to 8.0 when choline
was substituted with [1,2-2H4]-choline, suggesting a significant commitment to catalysis. The
D

(kcat/Km) determined in atmospheric oxygen decreased from a limiting value of 12.4 at low pH
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to a limiting value of 4.1 at high pH, consistent with the cleavage of C-H bond of choline being
fully rate-limiting at low pH.
1.7. Mechanistic studies. To determine the substrate recognition and specificity of
choline oxidase, choline and glycine betaine analogs were used as substrates and inhibitors,
respectively (30). As shown in Table 1, the competitive inhibition constant (Kis) decreased with
increasing number of methyl groups on the substrate. In contrast, replacement of the acetate
moiety of glycine betaine with neutral groups, such as methyl, ethyl, allyl, and 2-aminoethyl, did
not affect the binding of the ligand to the enzyme. This was suggested by the lack of changes in
the Kis value. These data indicated that the trimethylammonium moiety is important for substrate
recognition and specificity, but the acetate moiety is not. Additional evidence supporting the
importance of the trimethylammonium head group of the ligand was found when N,Ndimethylethanolamine and N-methylethanol were used as substrate analogs for choline. Steady
state kinetic data showed that the enzyme was capable of utilizing these compounds as substrate
but with a significant decrease in the kcat and kcat/Km values (Table 2). When 3,3-dimethyl-butan1-ol was used as substrate, kcat and kcat/Km values decreased 10 times as compared to those with
choline as substrate. This suggested that the positive charge at the trimethylammonium head
group was also important for substrate binding.
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Table 1.1. Inhibition studies of choline oxidase at pH 6.5a
Inhibitor
Structure
Kis, mM

R2

Glycine betaine

CH3
H3C N
COOCH3

15 ± 2

0.984

N,N-Dimethylglycine

CH3
COOH3C N
H

57 ± 1

0.995

N-Methylglycine

H
H3C N
H

405 ± 2

0.998

Tetramethylamine

CH3
H3C N CH3
CH3

11 ± 1

0.997

Trimethylamine

CH3
H3C N H
CH3

2.4 ± 0.2

0.998

Trimethylethylamine

CH3
H3C N C2H5
CH3

13 ± 2

0.988

Allyltrimethylamine

CH3
H3C N
CH3

15 ± 1

0.999

2-Amino-trimethylethylamine

CH3
H3C N
CH3

9 ± 1b

0.993

a

COO-

NH3

Choline oxidase activity was measured at varying concentrations of both
choline and inhibitor in air-saturated 50 mM sodium pyrophosphate, pH
6.5 and 25 oC, modified from Ref (30). bValue determined for the
protonated form of 2-amino-trimethylethylamine.
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Table 1.2. Steady state kinetic parameters for choline and N-substituted choline analogs as
substrates for choline oxidase at pH 8a
Substrate
Structure
kcat, s-1
kcat/Kmc, M-1s-1
R2
Choline
N,N-Dimethylethanolamine
N-Methylethanolamine
3,3-Dimethyl-1-butanol
a

CH3
H3C N
OH
CH3
CH3
H3C N
OH
H
CH3
H N
OH
H
CH3
H3C C
OH
CH3

86 ± 1

200,000 ± 10,000

0.995

18,400 ± 300

0.996

0.37 ± 0.01

710 ± 10

0.994

8.0 ± 0.1

7,900 ± 980

0.980

5.9 ± 0.1

Choline oxidase activity was measured at varying concentrations of organic substrate and oxygen
in 50 mM sodium pyrophosphate, pH 8, and 25 oC, data from Ref. (30). bkcat/Km is the kcat/Km value
for the organic substrate.
A subsequent study using pH and solvent viscosity effects with 3,3-dimethyl-butan-1-ol,
the isosteric analog of choline, was carried out to support the importance of the positive charge
on the trimethylammonium headgroup to substrate binding in choline oxidase (31). The pHdependent study of kcat and kcat/Km values of choline oxidase with 3,3-dimethyl-butan-1-ol
yielded pKa values that are comparable to the pKa values previously determined for choline
oxidase with choline as a substrate. However, the limiting values of the pH profiles for kcat and
kcat/Km were ~3 and ~400 times lower than those with choline, suggesting a significant decrease
in the efficiency of catalytic reaction. This is consistent with kcat/Km for oxygen when 3,3dimethyl-butan-1-ol was used as substrate being independent with a limiting value that was ~75
times lower than when choline was used. Solvent viscosity effects were used to examine
whether the kinetics steps of substrate binding limit the rate of substrate oxidation steps. As a
result, there was no viscosity effects observed for both kcat and kcat/Km, consistent with the
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chemical steps in substrate oxidation being fully rate-limiting for the overall turnover of the
enzyme with 3,3-dimethyl-butan-1-ol as substrate. Overall, the data presented in this study
agreed with previous proposed roles for the positive charge head group on choline being
essential for substrate binding and flavin oxidation.
Recently, an in-depth study of the catalytic steps in the reaction catalyzed by the
recombinant choline oxidase was carried out in our laboratory using steady state and pre-steady
state kinetics approaches under saturating oxygen (32). In that study, substrate and solvent
isotope effects were used to probe the status of the substrate OH and CH bond cleavage. The
results indicated that the reductive half-reaction that involves the cleavage of the substrate CH
bond was not masked by other kinetic steps, as suggested by the pH independent value of ~10.6
for D(kcat/Km) and a Dkred value of 8.9 at pH 10 for the anaerobic reduction of the bound-flavin by
choline in both protio and deuterated solvents. At pH 10, no solvent kinetic isotope effect was
observed for kcat/Km and kcat, and Dkcat and

D2O

kcat values were 7.3 and 1.1, respectively. These

results indicated that the removal of the substrate hydroxyl proton and the hydride transfer from
the substrate occur in a stepwise fashion with the formation of a transient alkoxide intermediate
species. Overall, the data from both steady state and pre-steady state kinetics provided evidence
for the chemical steps of the substrate oxidation by choline oxidase being fully rate-limiting for
both the overall turnover and the reductive half reaction involving the oxidation of choline to
betaine aldehyde.
The first oxidation step in the reaction catalyzed by choline oxidase was further
characterized by varying oxygen concentrations and temperature in the studies of the kinetic
isotope effects with deuterated choline (33).

The

D

kcat and

D

(kcat/Km) values were pH–

independent at saturating oxygen concentrations, but at ≤0.97 mM oxygen, these values
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decreased at high pH to a limiting value. The same pattern was observed for kcat and kcat/Km
when choline was used as substrate at oxygen concentrations ≤0.25 mM. These data suggested
that at high concentrations of oxygen, the partition forward to catalysis of the reduced form of
enzyme-betaine aldehyde complex was more favored than its reverse partition to the oxidized
enzyme-choline alkoxide species. When temperature was varied under saturating oxygen
concentrations, D(kcat/Km) was 10.6 ± 0.6 and temperature independent. The isotope effect on the
preexponential factor was determined to be 14 ± 3, which was too large for the classical over-the
barrier behavior for hydride transfer, whose preexponential factor was predicted to be between
0.7 and 1.7. In addition, similar enthalpies of activation, ∆H‡, were determined for choline and
1,2-[2H4]-choline, suggesting the cleavage of CH and CD bond did not follow the theoretical
model of H and D tunneling, which happen just below the transistion state. That is because this
model suggests that the lack of temperature dependence in the kinetic isotope effect is associated
with the lack of temperature dependence of the reaction rates with both H and D (34). In this
study, the similarities in preexponential factor values of kcat/Km and Dkcat/Km as well as in ∆H‡ for
kcat/Km values with choline and 1,2-[2H4]-choline implied that the tunneling of the hydride
observed for the case of choline oxidase may occurs quantum mechanically in a highly
preorganized active site, in which environmental vibrations shorten the distance between the
donor and the acceptor of the hydride allowing a more efficient hydride transfer (34-36).
The mechanism of oxidation of betaine aldehyde was also studied by using spectroscopic
and kinetic methods (37), in which the steady state and pre-steady state kinetics of choline
oxidase with betaine aldehyde and its analogue 3,3-dimethylbutyraldehyde were examined. (It
should be noted that 3,3-dimethylbutyraldehyde has the similar chemical structure as betaine
aldehyde but without the positive charge at the trimethylammonium head group [Figure 1.1]).
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betaine aldehyde

H

3,3-dimethylbutyraldehyde

Figure 1.1. Chemical structures of betaine aldehyde and 3,3-dimethylbutyraldehyde.

At saturating oxygen, the pH dependence of the kinetic parameters for betaine aldehyde
suggested that a catalytic base with a pKa value of ~6.7 was required for the oxidation of betaine
aldehyde. Under anaerobic conditions, choline oxidase was completely reduced in the presence
of choline or betaine aldehyde at pH 8 with a kred value of ≥48 s-1. However, only 10-26% of the
enzyme was reduced in the presence of 3,3-dimethylbutyraldehyde between pH 6 and 10.
Competitive inhibition was observed when enzyme activity was assayed with choline in the
presence of 3,3-dimethylbutyraldehyde.
betaine

aldehyde

exists

in

its

NMR spectroscopic analysis revealed that 99% of

hydrated

form

in

aqueous

solution,

while

3,3-

dimethylbutyraldehyde exists predominantly in its nonhydrated form. The reason that hydrated
form of betaine aldehyde is more favored stems from the stabilization of the hydroxyl group by
the positive charge at the trimethylammonium head group. In related work, kinetic data with
NAD+-dependent yeast aldehyde dehydrogenase indicated that the keto species of 3,3dimethylbutyraldehyde was reactive toward enzymic nucleophiles.

The data in this study

suggested that betaine aldehyde was required to be in its hydrated form for the oxidation to
glycine betaine. This was proposed to be a catalytic strategy that allowed choline oxidase to
catalyze two sequential oxidation reactions of an alcohol and an aldehyde within the same active
site and minimize the amount of energy spent for similar catalytic strategies.
In a search for the catalytic base of choline oxidase, His466 was substituted by both
alanine and asparatate (38, 39). The choice of mutation at His466 site in choline oxidase
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stemmed from previous studies of other enzymes that catalyze the oxidation of alcohol
substrates. Based on the studies of cholesterol oxidase (40, 41), cellobiose dehydrogenase (42),
and glucose oxidase (43, 44), a histidine is fully conserved within the active site of the enzyme
family, corresponding to His466 in choline oxidase, and this residue might act as the catalytic
base in the oxidation of alcohol substrates. If His466 were the catalytic base in the reaction, the
enzyme would be expected to be completely devoid of activity upon replacing His466 with an
alanine. However, the kinetic data for the His466Ala mutant indicated otherwise (38). The
enzyme was still active with this mutation, but the kcat and kcat/Km for choline as substrate at
atmospheric oxygen decreased 60- and 1000-fold, respectively, as compared to the wild type
enzyme. In contrast, the kcat/Km for oxygen was unaffected, suggesting the involvement of
His466 in the oxidation of choline but not in the reduction of oxygen.

The UV-visible

absorbance spectrum of His466Ala mutant as purified contained the oxidized form of the flavin,
whereas wild type choline oxidase as purified contained a mixture of oxidized flavin and its
anionic semiquinone (24, 25). Treatment of the His466Ala mutant with dithionite under aerobic
conditions at pH 8 resulted in the formation of the anionic flavin semiquinone, which was rapidly
returned to its oxidized form upon removal of excess dithionite by gel filtration. These data
indicated that upon replacing His466 with an alanine, the enzyme lost its ability to stabilize the
semiquinone form of flavin in the presence of oxygen. When the mutant protein was incubated
with 25 or 100 mM sodium sulfite for 3.5 h at pH 6.5, no change in the absorbance spectrum was
detected. This was another difference from the established spectroscopic properties of the wild
type enzyme, suggesting that the microenvironment of the flavin was significantly altered upon
mutating His466. This conclusion was also supported by the fact that the midpoint reduction
potential of two-electron transfer in the catalytically competent-enzyme substrate complex at pH
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7 was ~25 mV more negative than wild type enzyme. In the presence of the protonated
imidazole, the enzyme activity was partially rescued. In contrast, the neutral imidazole had no
effect. These data indicated that His466 in wild type enzyme was protonated. Both the pHprofiles of product inhibition and of kcat/Km of choline showed an upward shift of pKa, consistent
with a change in polarity of the active site of the enzyme. The relative timing of OH and CH
bond cleavage in substrate oxidation was also affected when His466 was replaced with alanine,
as suggested by the data from deuterium, solvent, and multiple kinetic effects. Overall, the data
ruled out the hypothesis of His466 that was the catalytic base in the reaction catalyzed by choline
oxidase. However, the positive charge contributed by the His466 is critical for stabilizing the
negative charges in the enzyme active site that found on the N(1) position of the flavin and on
the hydroxyl group of the substrate.
In another study, His466 was replaced with an asparatate (His466Asp) (39). With the
reversal of charge in the active site, the enzyme was completely devoid of activity, as indicated
by the lack of oxygen consumption and no bleaching of the 452 nm absorbance peak under
anaerobic conditions in the presence of 10 mM choline. However, the enzyme was still capable
of binding the substrate because there was a 4 nm bathochromic shift of the 452 nm peak that
was associated with an increase in absorbance at 375 nm in the UV-visible absorbance spectrum
of the flavin in H466D mutant. A Kd of 0.45 ± 0.04 mM was determined for the binding affinity
of the mutant protein for choline by monitoring the spectral changes with increasing
concentrations of choline. In contrast, the enzyme had lost its ability to bind glycine betaine
because there was no spectral change with increasing concentration of this ligand. The mutation
also caused 75% of the flavin to be uncovalently bound in choline oxidase. Anaerobic reduction
of the enzyme-bound flavin in His466Asp using xanthine and xanthine oxidase at pH 6 resulted
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in the formation of neutral hydroquinone, with no stabilization of the semiquinone intermediate.
The data presented in this study indicated that upon replacing a positive charge with a negative
charge near the N(1) locus of the flavin in choline oxidase, the enzyme has lost its ability to
stabilize the negative charges in the active site, which might lead to defective flavinylation of the
protein and change in eletrophilicity of the flavin, therefore resulting in loss of enzymatic
activity.
1.8. Summary. Based on the available data, a detailed mechanism for the reaction

catalyzed by choline oxidase was proposed. The enzyme catalyzes the oxidation of choline to
glycine betaine through two sequential flavin-linked hydride transfers with molecular oxygen as
the final electron acceptor and betaine aldehyde as the intermediate. In the first oxidation step
(Scheme 1.2), choline is converted into its alkoxide form by an active site base with pKa of ~7.5.
A hydride is transferred from the α-carbon of choline to the enzyme-bound flavin cofactor via
tunneling pathway. Consequently, the flavin is reduced and betaine aldehyde is formed as the
intermediate. In order to re-oxidize the cofactor for the next oxidation step, the enzyme uses an
oxygen molecule as the electron acceptor, resulting in the formation of hydrogen peroxide.
Betaine aldehyde is hydrated before the next hydride transfer step. The second hydride transfer
happens when the active site base abstract a proton from the gem-diol species of aldehyde,
resulting in another CH bond cleavage and the formation of a carboxylate product, glycine
betaine. The flavin is reduced by accepting the hydride from betaine aldehyde and reoxidized by
transferring two electrons to an oxygen molecule. The turnover cycle of choline oxidase is
completed when the product is released from the active site as the flavin becomes oxidized.
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2. Phenylhydrazine as a Mechanism-based Inhibitor

Hydrazine compounds have been studied extensively as mechanism-based inhibitors of a
wide variety of proteins, including heme-containing proteins such as horseradish peroxidase
(45), lactoperoxidase (46), hemoglobin (47), myoglobin (47), cytochrome P-450 (48), catalase
(49), flavoproteins such as monoamine oxidase (50) and trimethylamine dehydrogenase (51), and
copper proteins such as dopamine β–hydroxylase (52) and plasma amine oxidase (53). The
inhibition mechanisms of the enzymes with hydrazines were studied in detail for a few cases, in
which enzyme inactivation usually involved the generation of a carbon-centered radical or anion
at the active site (49, 51). These species were highly unstable and could react with the cofactors
or active site residues in the enzyme. For this reason, hydrazines were used in many chemical
modification studies with the aim of identifying important residues in the active site. Among
many hydrazines, phenylhydrazine was commonly used as one of the inhibitors of mitochondrial
monoamine oxidase, an enzyme found in the central nervous system that can breakdown
monoamine neurotransmitters (54).
2.1. In flavoenzymes.

Approaches for investigation the inhibition effects of

phenylhydrazine can be illustrated by studies of monoamine oxidase (50, 55) and trimethylamine
dehydrogenase (51, 56). Monoamine oxidase is a flavoenzyme that catalyzes the oxidative
deamination of neurologically active amines, e.g., serotonin.

Early studies showed that

hydrazines competed with the amine substrate for the enzyme active site (57-60). Inactivation of
the enzyme was proposed to involve oxidative processes (61-63) because maximal inhibition
could be achieved only in the presence of oxygen (64). Patek and Hellerman later conducted a
more detailed study on the inactivation of monoamine oxidase by phenylhydrazine (50). The
inactivation was shown to be complete and irreversible in the presence of oxygen. Under
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anaerobic conditions, the flavin cofactor was reduced by phenylhydrazine but could be
reoxidized when exposed to air to give an 80% recovery of enzyme activity. This observation
suggested the oxidation of the hydrazine inhibitor occurred before enzyme inactivation. A
Hammett study, in which the effects of nuclear substitution on the phenylhydrazine were
correlated with the rates of hydrazine-induced inhibition, suggested that flavin reduction by
phenylhydrazine was rate-limiting in the overall aerobic inhibition process. Spectroscopic data
showed that progressive incubation of the enzyme with phenylhydrazine under aerobic
conditions could cause an irreversible bleaching of the flavin peak. When inactive enzyme was
digested with trypsin, spectral analysis of the peptide containing the flavin cofactor gave
evidence for the formation of a flavin adduct. The intermediate phenyldiazene formed after the
oxidation of phenylhydrazine was thought to be responsible for the irreversible modification of
flavin cofactor.
The inhibitory mechanism of trimethylamine dehydrogenase with hydrazines has also
been studied.

Trimethylamine dehydrogenase has several properties in common with

mammalian monoamine oxidase, including covalently-bound flavin (65) and similar responses to
a variety of monoamine oxidase inhibitors (66). In work by Nagy et al. (51), the oxidation of
phenylhydrazine to the intermediate phenyldiazene was observed under aerobic and anaerobic
conditions. After the flavin peak at 454 nm was bleached upon incubation with phenylhydrazine,
a flavin species at 360 nm was seen. This flavin species was isolated by proteolytic digestion
and analyzed using mass spectrometry. Upon comparison with model compounds, the modified
flavin was identified as an arylated flavin. Generally, absorbance at 360 nm is indicative for
flavin modification at either the C(4a) or the N(5) position (67). The two sites of modification
are distinguished by the fact that N(5) flavin adducts are shifted ~30 nm hypsochromatically in 6
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M HCl, whereas C(4a) adducts are shifted ~30 nm in the opposite direction (67). The spectral
properties of the arylated flavin showed that C(4a) was the position of modification (Figure 1.1).
H
H3C
H3C
Z

X
N
N
H

O

N
N

Y

O

Figure 1.2. Structure of flavin C(4a) adduct. X, Y, and Z represent the side chains on flavin
cofactor.

The authors also investigated the reaction of phenylhydrazine and its intermediate phenyldiazene
with free flavin. Due to the photosensitivity of free flavin, the experiments were performed in
the dark. Phenylhydrazine seemed to react slowly with the flavin, while phenyldiazene reacted
rapidly to form the C(4a) adduct.

This observation supported the dehydrogenation of

phenyhydrazine by the enzyme being a rate-limiting step in the inhibitory mechanism.
2.2. In copper enzymes. The irreversible inactivation by hydrazine inhibitors was also

found in copper enzymes.

In a study by Fitzpatrick (52), dopamine β-hydroxylase was

inactivated with different hydrazines for the purpose of identifying the active site residues
around the copper cofactor. Several hydrazines were tested, including phenyl-, phenethyl-,
benzyl-, and methylhydrazine, and hydrazine itself. Enzyme inactivation was observed with
phenyl-, phenethyl-, benzyl-, and methylhydrazine, but not with hydrazine. The most rapid
inactivation was observed with phenylhydrazine. When the effect of different substrates of
dopamine β-hydroxylase upon the inactivation rate was tested, the hydrazines were divided into
two distinguishable classes. With phenyl-, phenethyl-, and methylhydrazine as inhibitors, the
oxidation of copper was required for the inactivation to occur, as suggested by the slower
inactivation rate in the presence of the reductant ascorbate. In contrast, the inactivation with
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benzylhydrazine required the enzyme in its reduced form, as suggested by the faster inactivation
rate in the presence of ascorbate. The substrate tyramine also had different effects on the rate of
inactivation when the same inhibitors were used: the inactivation rate decreased with
benzylhydrazine, increased with phenylhydrazine and methylhydrazine, but remained unchanged
with phenethylhydrazine. In the presence of both tyramine and ascorbate, the inactivation rate
decreased in both cases; therefore, the enzyme inactivation might occur at the active site. Such
observations were consistent with the proposed inhibitory mechanisms for monoamine oxidase
and trimethylamine dehydrogenase discussed above in that the inactivation of the enzyme by
hydrazine inhibitors involved the reduction of the enzyme cofactor. To directly test the ability of
the enzyme to generate radicals from hydrazines, the α-(-4-pyridyl-1-oxide)-N-tert-butylnitrone
(PORN) spin trap was employed to trap the carbon-centered radicals that formed in the reaction.
PORN was a reversible inhibitor of dopamine β-hydroxylase, and therefore had already bound to
the active site of the enzyme before the radicals were generated, resulting in the trapping of
various carbon-centered radicals. Analysis of the PORN-adduct in this study showed that the
inhibitory mechanism by monosubstituted hydrazines involved a generation of a hydrazine
cation radical, followed by the cleavage of the carbon-nitrogen bond to form a carbon-centered
radical and diazene (Scheme 1.2).
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E-Cu2+ + R-NH-NH2

E-Cu1+ + R-NH-NH2
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R

Scheme 1.3. Proposed inhibitory mechanism of dopamine β-hydroxylase by monosubstituted
hydrazines. Illustration based on the descriptions in ref (52).

The generation of a carbon-centered radical from the decomposition of phenylhydrazine radical
cation was observed in this study. Based on HPLC analysis, the stoichiometry of labeling of the
enzyme was 1 phenylhydrazine per subunit. This was consistent with the presence of one copper
in the active site of each monomer. Kinetic isotope effects were also used to gain insights into
the catalytic path.

When the benzylic hydrogens of benzylhydrazine were replaced with

deuterium, an isotope effect of ~13 was observed for Vmax, and the partition ratio for product
formation vs. inactivation decreased up to 11-fold. Therefore, the authors proposed that the
inactivation of the enzyme was due to abstraction of an electron from nitrogen instead of
abstraction of a hydrogen atom from the benzylic carbon.
2.3. In heme containing enzymes. The mechanism of inhibition by phenylhydrazine has

been studied for heme containing enzymes such as lacrimal-gland peroxidase (LGP) (68). LGP
is found in the secretion of the lacrimal gland and has the ability to prevent oxidative damage
and bacterial infection (69).

The oxidation of various substrates including halides,

pseudohalides, aromatic electron donors and xenobiotics is catalyzed by this enzyme. In a study
by Mazumdar et al. (68), LGP was inactivated irreversibly by the mechanism-based inhibitor
phenylhydrazine in the presence of H2O2. The enzyme could be protected from the inactivation
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in the presence of the electron donor SCN- and the free-radical trap 5,5-dimethyl-1-pyrroline Noxide (DMPO). The experiments with DMPO suggested the involvement of a radical species in
the inactivation process. Earlier studies with myoglobin (70, 71), hemoglobin (72, 73), catalase
(49), and cytochrome P-450 (48) showed the formation of a stable iron-phenyl complex in the
interaction of phenylhydrazine with the enzyme. The Soret shift in circular dichroic spectra was
used as one of the lines of evidence for the existence of an iron-phenyl complex in the inactive
enzyme. In the case of LPG, there was no shift in the Soret region upon treatment with
phenylhydrazine.

Instead, a significant loss of absorbance intensity at 409 nm and the

appearance of a negative ellipticity at 275 nm were observed. The far-UV circular dichroic
spectra of the native and modified enzymes were indistinguishable, ruling out inactivation due to
a gross structural change upon reaction of radicals with amino acid residues. The authors
proposed that the heme iron might be buried deep inside the enzyme where it was inaccessible to
the radicals, and the inactivation involved the modification of heme environment. A kinetic
study of LPG inactivation showed a stoichiometry of 2:1 of H2O2/phenylhydrazine. Therefore,
phenylhydrazine was oxidized through one-electron transfer to phenyl radicals, which bound to
the vicinity of the heme group, prevented electron transfer from the donor residue to the heme
ferryl group, and led to enzyme inactivation.

3. Tetranitromethane (TNM) as an Irreversible Inhibitor

Tetranitromethane (TNM) has been used in chemical modification of many proteins since
1930 (74). In many cases, incubation with this reagent resulted in the irreversible inactivation of
the enzyme. Detailed studies of the chemical modification using TNM have suggested that TNM
is specific for tyrosyl residues (75, 76). The reaction of TNM with tyrosine involves the
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formation of a charge-transfer complex with the phenol group of the amino acid, followed by the
generation of the phenoxide and nitrite radicals due to electron transfer. Nitration occurs when
phenoxide and nitrite radicals react, resulting in the release of a nitroformate anion (Scheme 1.4).
Additional reactions are possible due to the high reactivity of phenolate radicals with each other.
HO

NH2
OH

O

TNM

C(NO2)3HO
O

NH2

NO2
OH

Scheme 1.4. Nitration of tyrosyl residue by tetranitromethane.

TNM can also oxidize sufhydryl groups under the same conditions (77). In a study by
Sokolovsky et al. (77), disulfide and nitrite ions were generated in the presence of excess thiol.
Hydrolysis of the intermediate sulfenyl nitrate resulted in the formation of sulfinic acid as the
product. The ratio of sulfinic acid to disulfide formation depended on the conditions of the
reaction and the nature of the R group on the thiol compounds. A significant extent of other side
reactions is also observed for the reaction of enzymes with TNM. However, unwanted reactions
can be distinguished by lowering the pH because under acid conditions, i.e. pH ≤6, nitration of
tyrosine does not occur, whereas the modification is rapid at pH ≥9.
Despite the fact that the reaction of enzymes with TNM involves many side reactions, the
reagent has been used successfully in identifying active site tyrosines. The most common
problem is usually the poor solubility of TNM in water. Therefore, ethanol is usually used to
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prepare the TNM stock solutions.

The amount of TNM used to modify the enzyme is

consequently limited to 10% or less ethanol in the reaction mixture to prevent denaturation of the
enzyme by excess ethanol. Chemical modification using TNM is readily quantitated because
nitrotyrosine absorbs at 360 nm (Figure 1.3) (78).
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Figure 1.3. Typical spectra of a TNM-modified enzyme. Spectra obtained from the study on
chemical modification of choline oxidase with TNM, which described in details in Chapter V.

In a study by Gadda et al. (79), TNM was used for the modification of the flavoprotein
nitroalkane oxidase. Nitroalkane oxidase catalyzes the oxidation of nitroalkanes to aldehydes or
ketones with nitrite and hydrogen peroxide as the products. Upon incubation with TNM at pH
7.5, the enzyme was irreversibly inactivated. The rate of inactivation as a function of TNM
concentration followed saturation kinetics, suggesting that the inhibitor bound to the enzyme
prior to inactivation. In the presence of the catalytic product of the nitroalkane oxidase reaction,
the enzyme was protected from inactivation. This indicated that the nitration reaction occurred
at the active site of the enzyme. The UV-visible absorbance spectrum of the inactive enzyme
showed a significant perturbation in absorbance wavelength as compared to the active enzyme.
Comparison of tryptic maps of the treated and untreated enzymes followed by mass
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spectrometric analysis revealed a modified tyrosine at position 82. Based on earlier studies of
flavoenzymes such as D-amino acid oxidase (81), flavocytochrome b2 (82), p-hydroxybenzoate
hydroxylate (83), and glucose oxidase (84), a conserved tyrosine residue in the active site of
these enzymes is found to participate in binding the carboxylate moiety of the substrate. Because
the structure of carboxylate group is similar to that of the nitro group, the authors proposed that
this tyrosine might also be essential for binding the substrate in nitroalkane oxidase.

4. Effects of Freezing on Enzymes in Storage

For years, research laboratories routinely stored enzymes in frozen solutions because it is
believed that the long-term stability of enzymes in frozen solution is greater than in unfrozen
solutions.

However, in some cases, freezing and thawing may cause substantial enzyme

denaturation, which can be detected as alterations of the enzyme structure or loss of catalytic
activity. The low temperature perse and pH-shift of the solution as it cools (85, 86) usually
viewed as the main causes of enzyme denaturation in frozen storage. For this reason, freezing
can induce reversible inactivation of pH-sensitive enzymes.
4.1. pH-shift in storage buffers. Although buffers are often used to store enzymes in

order to maintain constant pH, evidences for pH shift upon freezing due to precipitation of the
less-soluble buffer component have been well documented. For Tris, citrate, and potassium
phosphate, the pH has been reported to change up to +1, -0.4, and +0.6 unit, respectively, upon
freezing (87, 88). The most dramatic pH changes have been observed with disodium phosphate
(Na2HPO4.12H2O) (85, 86) up to 3.5 pH units.

2

In work by Pikal-Cleland et al., protein

With the crystal structure of the nitroalkane oxidase obtained just recently by Nagpal et al. (80),
the tyrosine that has been identified in the study by Gadda et al. (79) was proposed to be at
position 398.
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denaturation during freezing and thawing in potassium phosphate (KP) and sodium phosphate
(NaP) buffer was studied (86). Tetrameric β-galactosidase was chosen in this study because its
inactivation can be monitored with large structural changes from tetramer to monomer. In
addition, earlier studies indicated that this protein lost activity when its subunits dissociated at
pH ≤ 6 (89, 90); the pH optimum for protein stability is between 6 and 8 (91, 92). In that study,
the pH changes during freezing were determined under nonequilibrium conditions. A combined
pH electrode was used with a reference solution containing potassium chloride, glycerol, and
formaldehyde that kept the electrolyte solution from freezing and enabled pH measurements
down to -30 oC. When the enzyme was stored at -10 oC in 100 mM or 10 mM NaP with initial
pH of 7.0, the pH significantly decreased to 3.8 or 5.5, respectively. In contrast, when the
enzyme was stored in 100 mM or 10 mM KP at -10 oC and pH 7, the pH of the frozen solutions
were 7.3 and 7.1, respectively. The magnitude of pH shifting in both buffers was dependent on
buffer concentrations with higher concentrations giving salt crystallization upon freezing. In the
ice-liquid interphase, water formed ice crystals and escaped from the buffer phase, resulting in a
more solute-concentrated buffer. The precipitation of buffer salts can happen at different times
and at various temperatures, depending on their solubility and buffer concentrations (93, 94). Ice
crystals usually form before the precipitation of buffer salts. These crystals pull the basic
phosphate species (i. e., HPO42-) away from the solution, thereby inducing a pH shift due to the
change in the ratio of base to acid in the buffer. In the case with NaP and KP buffers, disodium
salt is much less soluble in water than potassium salt because their eutectic points are -0.5 oC and
-13.7 oC, respectively. Therefore, the HPO42- species of NaP buffer was depleted from solution
much earlier than that of KP buffer leading to a greater change in pH. For β-galactosidase, the
lower recovery of activity and larger structural alterations was observed after freezing and
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thawing in NaP buffer than in KP buffer. This was used as evidence for the larger pH shift of
NaP. The effects of the freezing and thawing rates on activity recovery of the enzyme were also
investigated using different cooling and warming methods.

Data on activity recovery and

infrared spectroscopy of the enzyme structure revealed that less enzyme was denatured when fast
cooling and fast warming methods were used. This implied that rapid freezing and thawing can
minimize the time of exposure of the enzyme to low pH and high salt concentrations, thereby
resulting in less denaturation of enzyme from storage.
4.2. Reversible inactivation of enzymes. In limited cases, freezing can induce reversible

inactivation of pH-sensitive enzymes; this has been observed in the case of L-amino acid oxidase
(LAAO) from Crotalus adamanteus (95). LAAO is a snake venom enzyme that catalyzes a
flavin-dependent reaction involving the oxidative deamination of a number of L-amino acids. In
that study, the enzyme was stored in 0.2 M Tris-HCl, pH 7.8, and frozen at temperatures between
-5 to -60 oC. The maximal inactivation was observed when the enzyme was stored at -20 oC, as
suggested by the dramatic loss of enzymatic activity. Repeated freezing and thawing did not
affect the rate of inactivation. No inactivation was observed in the absence of freezing. The
degree of inactivation was directly dependent on Tris-HCl buffer concentrations between 2 mM
to 200 mM, but was independent of enzyme concentrations in storage.

Under anaerobic

conditions, a protective effect against freezing inactivation was observed in the presence of
substrates, such as L-leucine and L-arginine. However, there was no protection when the
enzyme was reduced anaerobically with dithionite.

Glycerol and dimethyl sulfoxide also

protected the enzyme. This was explained with the hypothesis that glycerol and methylsulfoxide
influenced the ice structure in a way that prevented the formation of the inactive form of the
enzyme.

Spectroscopic data from protein fluorescence showed that the inactive enzyme
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maintained its native conformation. UV-visible absorbance spectra of the enzyme-bound FAD
cofactor showed the inactivation of the enzyme was associated with 7 nm and 12 nm
hypsochromic shifts of the 462 nm and 390 nm peaks, respectively. Photoreduction in the
presence of EDTA was used to examine the reduction properties of the FAD in the inactive
enzyme. The rate of the reduction was 10-fold lower than that of active enzyme and only 50% of
flavin semiquinone could be formed. Based on spectroscopic and photoreduction data, the
authors concluded that the microenvironment of the flavin in the inactive form of the enzyme
was significantly affected. The reactivation process of LAAO was also investigated. The
enzyme was fully reactivated at pH 5 by increasing the temperature. Adjustment of the pH to 5
or an increase in temperature alone could not reactivate the enzyme; both were required for a full
reactivation of LAAO. When the UV-visible absorbance of FAD was monitored during the
reactivation process, the absorbance spectrum eventually became similar to that of the native
enzyme, which further supported the conclusion that the inactivation of the enzyme was
associated with changes in the flavin microenvironment.

The temperature-dependence of

reactivation yielded a ∆H‡ of 36 to 41 kcal mol-1 (151 to 171 kJ mol-1). These large ∆H‡ values
from temperature reactivation were in conflict with spectroscopic data, which showed no large
protein conformational change. The authors explained the effect of temperature on freezing
inactivation using the following model:

Eact

E*

k

Ein

where Eact and Ein represent the active and inactive forms of enzyme, E* represents a metastable
form of enzyme that is in equilibrium with Eact, and k represents the rate constant for the
conversion from E* to Ein.

Eact

E* was produced as a result of ice formation, therefore

E* had large ∆H‡. The rate of inactivation, k, was governed by a small ∆H‡ if the
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conversion from E*

Ein involved only a few breakages of chemical interactions. For

these reasons, the maximal inactivation was observed at the midpoint temperature, i. e. -20 oC,
due to high concentration of E* and the rate of inactivation was still significant.

When the

enzyme was stored at -2 oC, no significant inactivation was observed because there was not
enough E*. At -60 oC, most of the enzyme was in the E* form and k had become so low that the
inactivation was not detectable anymore.
The freezing-inactivation study by Curti et al. was done early before the pH shift in
storage buffers was investigated extensively. However, the authors also tested the effect of
different buffers on the inactivation of LAAO during freezing. Lower inactivation rates were
observed when sodium or potassium phosphate was used as buffers instead of Tris. The authors
proposed that phosphates protected the enzyme from freezing inactivation.

5. Hysteretic Behavior in Enzymes
5.1. General description of hysteretic behavior in enzymes. The term “hysteresis” came

from physics and was defined as a slow response that was exhibited by a body in reacting to
outside forces. Hysteretic behavior of enzyme, on the other hand, was defined as a slow
response to a change in ligand concentrations (96). Such behavior was observed most often in
regulatory enzymes as kinetic cooperativity; however, there have been reports of hysteretic
enzymes found in other classes, such as ovoperoxidase (97) and leucocyte proteinase (98).
In the 1970s, extensive studies on hysteretic enzymes were carried out by Frieden (96,
99). In his studies, two mechanisms were believed to be responsible for the slow response in

enzymes: 1) isomerization processes and 2) displacement of a tightly bound ligand by another
with a different effect on activity. Isomerization processes usually involved conformational
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changes in the enzyme that were slow relative to the rate of the reaction (96). Generally, the
rates of conformational change in enzymes are so fast as compared to the rate of the catalytic
reaction that they are difficult to detect.

However, it is possible to have multiple local

conformational changes that occur one after another causing a delay in enzymatic activity.
Displacement reactions involved the dissociation of the ligand from the enzyme (96). In the
presence of two different ligands, i.e., enzyme inhibitor and substrate, the activity of the enzyme
increased upon the displacement of the inhibitor by the substrate at a rate that depended on how
rapidly the inhibitor is released from the enzyme surface. Therefore, the longer the inhibitor
bound, the longer the lag in enzymatic activity.
5.2. Analysis of hysteretic behavior. The analysis of hysteric behavior in enzymes is

fairly complicated because the rate of product accumulation or substrate depletion in activity
assays occurs following single exponential function (99). Frieden approached the problem by
introducing an equation that describes a burst or lag in product appearance (or substrate
consumption), which is followed by a linear accumulation of product:
vt = vf + (vi − vf )e − kt

(1)

where vt is the velocity as a function of time, vf is the velocity after the burst or lag, vi is the
initial velocity, and k the observed rate for the transition of one form to another form of enzyme.
This equation is applicable to hysteretic mechanisms with the assumption that the kinetic
measurements are performed in the absence of substrate depletion or product accumulation.
However, such assumption may affect the evaluation of k if k is dependent on substrate or
enzyme concentrations.
Frieden’s study on hysteretic behavior of the enzymes extended to detailed analysis of
different enzyme systems. The more complicated the system, the more difficult the analysis.
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Therefore, it should be noted that the summary provided herein only included a portion of the
hysteresis theory that is applicable for the purpose of the study presented in this thesis. For a
more detailed treatment of this topic, the reader is referred to Ref. (96, 99).

6. Goals

The oxidation of choline to glycine betaine is catalyzed by choline oxidase through two
sequential flavin-linked hydride transfers with molecular oxygen as the final electron acceptor
and betaine aldehyde as the intermediate. The study of this enzyme is of importance for medical
and biotechnological applications because the product of its catalytic reaction, glycine betaine, is
a compatible solute that is accumulated in many pathogenic bacteria (100-109), and transgenic
plants (12, 16, 18, 20, 110, 111) in response to adverse hyperosmotic environment (13, 14).
Therefore, the study of choline oxidase has the potential for the development of therapeutic
agents that target the biosynthesis of glycine betaine in human pathogenic bacteria, and for the
engineering of drought and salt stress resistance in beneficial bacteria and crop plants. For this
reason, the aim of the research presented herein is to investigate the mechanism of enzyme
inactivation through mechanism-based inhibition and storage conditions.
To understand the active site structure of choline oxidase is extremely important for the
mechanistic study of an enzyme. In this regard, chemical modification of choline oxidase is an
effective tool for identifying the active site residues that are essential to catalysis. Active site
modifications require the use of irreversible mechanism-based inhibitors as labels.
Consequently, the first step in this study was to search for an irreversible inhibitor for choline
oxidase using compounds with understood inhibitory mechanisms.

Phenylhydrazine and

tetranitromethane were found to inactivate choline oxidase to significant extends, so the kinetics
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of inactivation and the structural properties of the inactive enzyme were carefully studied in this
research.
During the procedure employed to purify choline oxidase, choline oxidase showed a
significant hysteretic behavior after storing at pH 6 and -20 oC (Fan Fan, Prashanthi Menon, Jane
V. Hoang, and Giovanni Gadda; unpublished observations), a step used to fully oxidize the
enzyme-bound flavin (30), suggesting that the enzyme might be affected by freezing at low pH.
Since such freezing effects have rarely been reported for enzyme in storage, investigation on the
effect of storage temperature and pH on the biophysical and catalytic properties of choline
oxidase can give insights into such phenomenon. In addition, storing purified enzymes in frozen
solution was almost always employed in our laboratory. Therefore, to understand the inhibitory
mechanism of choline oxidase by freezing can help choosing the appropriate conditions for
enzymes in storage.
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Chapter II
MATERIAL AND METHODS

1. Materials and Enzyme Preparations

Choline chloride was from ICN Pharmaceutical (Aurora, OH). Glycine betaine was from
Sigma-Aldrich (St. Louis, MO). 2-Hydazino-N,N,N-trimethyl-2-oxo-ethanaminium chloride was
purchased from Acros Organics N.V. (Fair Lawn, NJ).
isonicotinic

acid,

3-dimetylamino-1-propyne,

Trans-2-phenylcyclopropylamine,

allyltrimethylammonium

chloride,

phenylhydrazine, and tetranitromethane were from Aldrich. TPCK-treated trypsin was purchased
from Worthington. Recombinant choline oxidase from Arthrobacter globiformis strain ATCC
8010 was expressed from plasmid pET/codA1 and purified to homogeneity as described
previously (1). Fully oxidized choline oxidase was prepared as described in ref. (2), and was
stored at -20 oC in either 20 mM Tris-Cl, pH 8, or 20 mM sodium phosphate, 20 mM sodium
pyrophosphate, pH 6. The enzyme was rapidly thawed on ice prior of each experiment. When
needed, buffers were changed either by gel filtration through disposable PD-10 desalting
columns (Amersham Pharmacia Biotech, Piscataway, NJ) or dialysis for 19 h at 4 oC. The
concentration of choline oxidase was determined spectrophotometrically at 454 nm using the
previously reported ε454 value of 11.4 mM-1cm-1 (3). All kinetic parameters determined were
expressed per active site oxidized flavin content (3). All other reagents were of the highest purity
commercially available.

2. Instruments

UV-visible absorbance spectra were recorded using an Agilent Technologies diode-array
spectrophotometer model HP 8453 equipped with a thermostated water bath. Tryptic maps were
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obtained using a high performance liquid chromatograph (HPLC) model LC-10AT from
Shimadzu. Fluorescence emission spectra were recorded with a Shimadzu Spectrofluorometer
model RF-5301 PC thermostated at 15 oC. Circular dichroism spectra were acquired using a
Jasco J-810 spectropolarimeter at 5 oC. Enzyme activity was measured polarographically by
monitoring the rate of oxygen consumption with a Hansatech oxygen electrode (HansaTech Oxy32) thermostated at 25 oC.

3. Enzyme Assay

Enzyme activity was measured with the method of the initial rates (4) in air-saturated 50
mM potassium phosphate at pH 7 by monitoring the rate of oxygen consumption with a
computer-interfaced Oxy-32 oxygen-monitoring system

(Hansatech Instrument Ltd.)

thermostated at 25 oC. The reactions were started by the addition of choline oxidase to a 1 ml
reaction mixture. Unless otherwise stated, the final concentration of enzyme in the reaction
mixture was in 0.1 to 0.5 µM range, and the concentration of choline was between 0.05 and 10
mM.
Chemical modification was carried out by incubating the enzyme in 20 mM Tris-Cl at pH
8 and 20 oC in the presence of ligand. The concentration of ligand in the incubation was in a
range from 0.5 and 50 mM.

At different times, aliquots were withdrawn and assayed

polarographically for enzymatic activity with choline as substrate.
For freezing inactivation study, rates of oxygen consumptions of the enzyme species
showing slow onsets of steady state during turnover were determined from the linear portions of
the traces, i.e., after steady state was achieved. The pH effects on the fast rate of reactivation of
choline oxidase (kc) were determined by measuring the activity of the enzyme species with
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hysteretic behavior in 50 mM [Tris (hydroxymethyl) aminomethane] with the pH in a range from
6.5 to 9.6 at 25 oC. The temperature effects on the slow rate of activation of choline oxidase
(kact) were determined by incubating the inactive enzyme in the range from 20 to 39 oC at pH 6,
and the activity was measured in 50 mM morpholinoethansulfonic acid, at pH 6 and 25 oC.

4. Tryptic Digestion

To identify the modified site by mechanism-based inhibitor that resulted in enzyme
inactivation, the enzyme was incubated with the inhibitors in the presence and absence of 140
mM glycine betaine in 20 mM Tris-Cl at pH 8 and 20 oC. Enzyme activity was monitored over
time until ~90% of the enzyme became inactivated. Gel filtration was used to remove the excess
reagents. The inactive enzyme was denatured with 10% (w/v) trichloroacetic acid and incubated
on ice for 30 min before centrifugation at 12000g for 20 min. The pellets were washed with 10%
trichloroacetic acid followed by an ice-cold acetone/HCl (39:1) mixture, resuspended in 0.1 mL
of 8 M urea, 4 mM CaCl2, and 0.4 M ammonium bicarbonate, pH 8, and allowed to stand for 1 h
at 37 C. The solutions were then diluted with 0.3 mL of water before the addition of trypsin to
a final concentration of 3% (w/w, trypsin/choline oxidase). After 4 h incubation at 37

C, a

second aliquot of trypsin (1% w/w final concentration) was added, and the mixture was allowed
to react for a further 15 h at 37 C. The digestion was stopped with trifluoroacetic acid (1% final
concentration). Purification of peptides was carried out by HPLC using a Shimadzu instrument
equipped with a model SPD-M10A photodiode array detector and a µBondapak C18 (15 × 4.6
mm) reverse-phase column at a flow rate of 1 mL min-1. Eluent A was 0.05% aqueous
trifluoroacetic acid, and eluent B was 0.04% trifluoroacetic acid in acetonitrile. The
chromatography was carried out with a linear gradient from 5% to 50% eluent B over 90 min.
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Peptides were collected manually. For the identification of the modified peptide, MALDI-TOF
mass spectrometry was used in both the positive and negative ion modes with 50:50
methanol/acetonitrile matrix.

5. Spectral Studies

In freezing inactivation study, absorbance, fluorescence, and circular dichroic spectra
were determined in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6, at 15 oC.
The concentration of enzyme in flavin content was: 11 µM for the UV-visible absorbance
spectra, 3 µM for the protein fluorescence emission spectra (with λex at 285 nm), 11 µM for the
flavin fluorescence emission (with λex at ~455 nm), and 2.5 µM, 50 µM, and 168 µM for the CD
spectra of the protein in the far-UV, near-UV, and visible regions of the spectra, respectively.

6. Data Analysis

Data were fit with KaleidaGraph software (Synergy Software, Reading, PA) and Enzfitter
software (Biosoft, Cambridge, UK). The steady state kinetic parameters were determined by
fitting the data to the Michaelis-Menten equation for one substrate. Time course of inactivation
of choline oxidase was fit with eq (1), where A represents the residual activity at a given time (t),
A0 is the initial activity, and kobs is the observed rate of the inactivation. The rates of inactivation
of the enzyme were fit to eq (2), where kinact is the first-order rate constant for the conversion of
the reversibly formed enzyme-inhibitor complex to irreversibly inactivated enzyme, I is the
concentration of the mechanism-based inhibitor, and KI is the dissociation constant of the
mechanism-based inhibitor from the enzyme.
A = A0 e − kobst

(1)
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k obs =

k inact [I]
[ I] + K I

(2)

In freezing inactivation study, the first-order rate constants for the fast and pH-dependent
activation of the inactive form of choline oxidase (kc) were determined by fitting the timecourses of oxygen consumption to eq 3, which was modified from Frieden (5), where vf
represents the observed rate of reaction after reaching steady state, and [O2]o is the initial
concentration of oxygen. The pH dependence of kc was determined by using eq 4, which
describes a curve with a slope of +1 and a plateau region at high pH where C represents the pHindependent value. The apparent rates of activation of the enzyme at any given temperature were
determined by fitting the observed rates of oxygen consumption at any given incubation time
with eq 5 that describes a single exponential process. Here,

app

kact is the apparent first-order rate

constant for the temperature-dependent slow activation of the inactive form of choline oxidase, t
is time, At is the value of enzymatic activity, Ao is the amplitude of the total change, and A∞ is the
enzymatic activity at infinite time. The temperature dependence of kact was determined by using
the Eyring's equation (eq 6), where kact is the first-order rate constant for enzyme activation, kB
and h are the Boltzmann and Planck constants, T is the absolute temperature in Kelvin, R is the
‡

‡

gas constant with a value of 8.315 J mol-1 K-1, and ∆H and ∆S are the enthalpy and entropy of
activation, respectively.
1 − e − kc t
∆[O 2 ] t = vf t − vf
+ [O 2 ]o
kc

(3)

⎛
⎜
C
log k c = log⎜
⎜
10 −pH
+
1
⎜
⎝ 10 −pKa

(4)

At = A∞ − Ao e − t

app

k act

⎞
⎟
⎟
⎟
⎟
⎠

(5)
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−
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(6)
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Chapter III
CHEMICAL MODIFICATION OF CHOLINE OXIDASE: THE SEARCH FOR THE
INHIBITOR

Abstract

Choline oxidase is a flavin-dependent enzyme that catalyzes the oxidation of choline to
glycine-betaine, with oxygen as electron acceptor. In the absence of crystallographic data,
chemical modification was employed in order to identify essential catalytic residues in the active
site of choline oxidase. Because mechanism-based inhibitors are needed for the modification of
enzyme, seven reagents were tested in this study as inhibitors for choline oxidase: 2-hydrazinoN,N,N-trimethyl-2-oxopethanaminium, allyltrimethylammonium, isonicotinic acid hydrazide, 3dimethylamino-1-propyne,
tetranitromethane.

trans-2-phenylcyclopropylamine,

phenylhydrazine,

and

The results showed significant inactivation of the enzyme with

tetranitromethane and phenylhydrazine at concentration ranging from 0.5 to 5.0 mM and 0.1 to
2.0 mM, respectively. The observed inactivation rates at these concentrations ranged from 0.1 to
0.4 h-1 with tetranitromethane and from 0.5 to 4.4 h-1 with phenylhydrazine.

Enzyme

inactivation was also observed with trans-2-phenylcyclopropylamine in the concentration range
from 10 to 50 mM to yield a kobs value from 0.2 to 0.3 h-1, respectively. The results in this study
helped identifying three possible inhibitors that might be used for the modification of choline
oxidase.
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Introduction

Choline oxidase (CHO; E.C. 1.1.3.17) from Arthrobacter globiformis catalyzes the
oxidation of choline to glycine betaine through two flavin-linked sequential hydride transfers
with betaine aldehyde as the intermediate and molecular oxygen as the final electron acceptor
(Scheme 3.1).

+

(CH3)3N

Choline

OH

H2O2
+

(CH3)3N
O2

Betaine aldehyde

O

H2O2
(CH3)3N+
H2O, O2

O
O

Betaine

Scheme 3.1. Reaction catalyzed by choline oxidase.

The enzyme is a homodimer of 120 kDa, with each monomer containing covalently bound FAD
(1).

The study of choline oxidase was considered of importance to both medical and

biotechnological applications because the product of its catalytic reaction, glycine betaine, was
found to accumulate in the cytoplasm of cells to prevent dehydration and plasmolysis in adverse
hyperosmotic environments (2, 3) in pathogenic bacteria (4-13) and transgenic plants (14-19).
Consequently, the study of choline oxidase has potential for the development of therapeutic
agents targeted at the inhibition of glycine betaine biosynthesis and for the engineering of
drought resistance in economically relevant crops.
In earlier work, we have reported the cloning and expression of the gene coding for
choline oxidase from A. globiformis strain ATCC 8010 in E. coli (1). The chemical mechanism
for the oxidation of choline catalyzed by choline oxidase has been recently elucidated using
kinetic isotope effects, and is consistent with the quantum mechanical transfer of a hydride from
the substrate α-carbon to the enzyme-bound flavin cofactor occurring from an activated alkoxide
form of choline (20, 21). Such an alkoxide species has been proposed to form by the action of an
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active site base with pKa of ~7.5 (22-24), and to be electrostatically stabilized in the enzyme
active site by the imidazolium side chain of His466 (25, 26).
Despite the wealth of information that has previously been obtained on choline oxidase
using kinetic and mechanistic studies, the lack of 3-dimensional structure hindered the
understanding of the catalytic reaction at structural level. In the absence of crystallographic data,
chemical modification is a powerful technique that can be used to identify the essential residues
in the active site of enzyme.

This technique involves experiment with mechanism-based

inhibitors of the enzyme. If the inhibitor reacts with side chains of an amino acid and lead to
enzyme inactivation, then it is very likely that this amino acid plays important roles in enzyme
function, such as participating directly in catalytic process, participating in binding interaction
with a substrate, or stabilizing the enzyme conformation that is required for catalysis. In this
chapter, several reagents were employed for the chemical modification studies of choline
oxidase, in which only the highly reactive and selective reagents will be chosen for more detailed
study.
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Material and Methods
Materials and enzyme preparations. Choline chloride was from ICN Pharmaceutical

(Aurora, OH). Glycine betaine was from Sigma-Aldrich (St. Louis, MO). 2-hydazino-N,N,Ntrimethyl-2-oxo-ethanaminium chloride was purchased from Acros Organics N.V. (Fair Lawn,
NJ).

Trans-2-phenylcyclopropylamine,

isonicotinic

acid,

3-dimetylamino-1-propyne,

allyltrimethylammonium chloride, phenylhydrazine, and tetranitromethane were from Aldrich.
TPCK-treated trypsin was purchased from Worthington (Lakewood, NJ). Recombinant choline
oxidase from Arthrobacter globiformis strain ATCC 8010 was expressed from plasmid
pET/codA1 and purified to homogeneity as described previously (1). Fully oxidized choline
oxidase was prepared as described in ref. (24), and was stored at -20 oC in either 20 mM Tris-Cl,
pH 8, or 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6. The enzyme was
rapidly thawed on ice prior of each experiment. The concentration of choline oxidase was
determined spectrophotometrically at 454 nm using the previously reported ε454 value of 11.4
mM-1cm-1 (23). All kinetic parameters determined were expressed per active site oxidized flavin
content (23). All other reagents were of the highest purity commercially available.
Instruments. Inactivation of enzyme was carried out by incubating the enzyme with the

inhibitor in Eppendorf Mastercycler model 5333 thermostated at 20 oC. Enzyme activity was
measured polarographically by monitoring the rate of oxygen consumption with a Hansatech
oxygen electrode (HansaTech Oxy-32) thermostated at 25 oC.
Enzyme assays. The enzyme was incubated in 20 mM Tris-Cl at pH 8 and 20 oC in the

presence of chosen reagent.

At different times, aliquots were withdrawn and assayed

polarographically for enzymatic activity. Enzyme activity was measured with the method of the
initial rates (27) in air-saturated 50 mM potassium phosphate at pH 7 by monitoring the rate of
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oxygen consumption with a computer-interfaced Oxy-32 oxygen-monitoring system (Hansatech
Instrument Ltd.) thermostated at 25 oC. The reactions were started by the addition of choline
oxidase to a 1 ml reaction mixture. Unless otherwise stated, the final concentration of enzyme in
the reaction mixture was in the 0.1 to 0.5 µM range, and the concentration of choline was 10
mM.
Data analysis. Data were fit with KaleidaGraph software (Synergy Software, Reading,

PA). The steady state kinetic parameters were determined by fitting the data to the MichaelisMenten equation for one substrate. Time course of inactivation of choline oxidase was fit with
eq (1), where A represents the residual activity at a given time (t), A0 is the initial activity, and
kobs is the observed rate of the inactivation.
A = A0 e − kobst

(1)
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Results

In order to ensure that enzyme inactivation was only due to the reaction of choline
oxidase with the reagent being tested, a control experiment was carried out in which the enzyme
was incubated in 20 mM Tris-Cl, pH 8, at 20 oC. As show in Figure 3.1, the residual activity of
choline oxidase remained constant up to two hours of incubation; therefore, all inactivation

Activity, %

experiments were done under these conditions.

100

kobs = ~0 min-1

10
0

30

60

90

120

Time, min
Figure 3.1. Stability of choline oxidase in 20 mM Tris-Cl, pH 8, at 20 oC. Enzyme activity was
measured by monitoring the rate of oxygen consumption in air-saturated 50 mM potassium
phosphate at pH 7 and 25 oC. The data were fit with Eq. (1).

Seven reagents were chosen to test as inhibitors of choline oxidase in 20 mM Tris-Cl, pH
8, at 20 oC (Table 3.1). The choice of reagents was based on structural similarity of the reagents
with the substrates or product of the enzyme or the previously studied inhibitory mechanism of
the reagents. As shown in Table 3.1, there was no enzyme inactivation observed with 2hydrazino-N,N,N-trimethyl-2-oxopethanaminium, allyltrimethylammonium, isonicotinic acid
hydrazide, and 3-dimethylamino-1-propyne. In contrast, significant enzyme inactivation was
observed with phenylhydrazine and tetranitromethane. Trans-2-phenylcyclopropylamine also
inactivated choline oxidase but at an observed rate that was ~200-fold less than that of
phenylhydrazine and 40-fold slower than that of tetranitromethane.
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Table 3.1. List of reagents tested as mechanism-based inhibitors for choline oxidase.a
Reagent name
Structure
Concentrations,
kobs,b
mM
h-1
H
20-50
0
2-hydrazino-N,N,N-trimethylCH3
N
2-oxo-ethanaminium
NH2
H3C N

allyltrimethylammonium
isonicotinic acid hydrazide

CH3 O
CH3
H3C N
CH3
O

N
H

N

trans-2phenylcyclopropylamine
phenylhydrazine

0

20-50

0

10-50

0.2-0.3

0.1-2.0

0.5-4.4

10-50

0

0.5-5.0

0.1-0.4

NH2

NH2
H
N

NH2

3-dimethylamino-1-propyne

CH3
H3C N

tetranitromethane

NO2
O2N
NO2
NO2

a

20-50

Data were obtained by incubating the enzyme with the reagent in 20 mM Tris-Cl, pH
8, at 20 oC. Activity was monitored over time with choline as substrate in 50 mM
potassium phosphate, pH 7, at 25 oC.
b
Observed rate of enzyme inactivation, which was determined by fitting the residual
activity at a given time t to the single exponential decay equation (Eq. 1).
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Discussion

The flavoprotein choline oxidase from Arthrobacter globiformis catalyzes the two steps
oxidation of a primary alcohol substrate to a carboxylate product with an aldehyde intermediate.
In the absence of crystallographic data, chemical modification was employed in order to identify
essential catalytic residues in the active site of choline oxidase. The study presented herein
helped identifying mechanism-based inhibitors that may be used for enzyme modification. Out
of the seven reagents tested (Table 3.1), the enzyme showed significant inactivation rates only
with

tetranitromethane,

phenylhydrazine,

and

trans-2-phenylcyclopropylamine.

Tetranitromethane (TNM) has been used for chemical modification of amino acid residues in
peptides, polymers, and proteins since 1930 (28-30). This reagent is well known for its high
specificity for the nitration of tyrosyl residues with distinct visible absorbance that can be
quantitated

using

spectrophotometry

(30).

Phenylhydrazine

and

trans-2-

phenylcyclopropylamine has been used in modification of flavoenzymes such as monoamine
oxidase (31, 32) and trimethylamine dehydrogenase (33, 34). Enzyme inactivation with these
two reagents usually involves the generation of a carbon-centered radical or anion at the enzyme
active site, resulting in the formation of flavin C4(a) adduct.

In this study, significant

inactivation rates were observed for choline oxidase with all three reagents; however, more
specific experiments must be performed in order to distinguish the amino acid that has been
modified. Detailed studies on the modification of choline oxidase with phenylhydrazine and
tetranitromethane are illustrated in Chapter 4 and Chapter 5, respectively.

60
References

(1)

Fan, F., Ghanem, M., and Gadda, G. (2004) Cloning, sequence analysis, and purification
of choline oxidase from Arthrobacter globiformis: a bacterial enzyme involved in
osmotic stress tolerance. Arch. Biochem. Biophys. 421, 149-158.

(2)

McNeil, S. D., Nuccio, M. L., and Hanson, A. D. (1999) Betaines and related
osmoprotectants. Targets for metabolic engineering of stress resistance. Plant Physiol.
120, 945-50.

(3)

Burg, M. B., Kwon, E. D., and Kultz, D. (1997) Regulation of gene expression by
hypertonicity. Annu. Rev. Physiol. 59, 437-55.

(4)

Bae, J. H., Anderson, S. H., and Miller, K. J. (1993) Identification of a high-affinity
glycine betaine transport system in Staphylococcus aureus. Appl. Environ. Microbiol. 59,
2734-6.

(5)

Culham, D. E., Emmerson, K. S., Lasby, B., Mamelak, D., Steer, B. A., Gyles, C. L.,
Villarejo, M., and Wood, J. M. (1994) Genes encoding osmoregulatory proline/glycine
betaine transporters and the proline catabolic system are present and expressed in diverse
clinical Escherichia coli isolates. Can. J. Microbiol. 40, 397-402.

(6)

Graham, J. E., and Wilkinson, B. J. (1992) Staphylococcus aureus osmoregulation: roles
for choline, glycine betaine, proline, and taurine. J. Bacteriol. 174, 2711-6.

(7)

Kaenjak, A., Graham, J. E., and Wilkinson, B. J. (1993) Choline transport activity in
Staphylococcus aureus induced by osmotic stress and low phosphate concentrations. J.
Bacteriol. 175, 2400-6.

(8)

Kunin, C. M., and Rudy, J. (1991) Effect of NaCl-induced osmotic stress on intracellular
concentrations of glycine betaine and potassium in Escherichia coli, Enterococcus
faecalis, and staphylococci. J. Lab. Clin. Med. 118, 217-24.

(9)

Le Rudulier, D., Bernard, T., Goas, G., and Hamelin, J. (1984) Osmoregulation in
Klebsiella pneumoniae: enhancement of anaerobic growth and nitrogen fixation under
stress by proline betaine, gamma- butyrobetaine, and other related compounds. Can. J.
Microbiol. 30, 299-305.

61
(10)

Le Rudulier, D., and Bouillard, L. (1983) Glycine betaine, an osmotic effector in
Klebsiella pneumoniae and other members of the Enterobacteriaceae. Appl. Environ.
Microbiol. 46, 152-9.

(11)

Pichereau, V., Bourot, S., Flahaut, S., Blanco, C., Auffray, Y., and Bernard, T. (1999)
The osmoprotectant glycine betaine inhibits salt-induced cross- tolerance towards lethal
treatment in Enterococcus faecalis. Microbiology 145, 427-35.

(12)

Pourkomailian, B., and Booth, I. R. (1992) Glycine betaine transport by Staphylococcus
aureus: evidence for two transport systems and for their possible roles in osmoregulation.
J. Gen. Microbiol. 138, 2515-8.

(13)

Peddie, B. A., Wong-She, J., Randall, K., Lever, M., and Chambers, S. T. (1998)
Osmoprotective properties and accumulation of betaine analogues by Staphylococcus
aureus. FEMS Microbiol. Lett. 160, 25-30.

(14)

Sakamoto, A., Alia, Murata, N., and Murata, A. (1998) Metabolic engineering of rice
leading to biosynthesis of glycinebetaine and tolerance to salt and cold. Plant Mol. Biol.
38, 1011-9.

(15)

Sakamoto, A., Valverde, R., Alia, Chen, T. H., and Murata, N. (2000) Transformation of
Arabidopsis with the codA gene for choline oxidase enhances freezing tolerance of
plants. Plant J. 22, 449-53.

(16)

Alia, Kondo, Y., Sakamoto, A., Nonaka, H., Hayashi, H., Saradhi, P. P., Chen, T. H., and
Murata, N. (1999) Enhanced tolerance to light stress of transgenic Arabidopsis plants that
express the codA gene for a bacterial choline oxidase. Plant Mol. Biol. 40, 279-88.

(17)

Holmström, K. O., Somersalo, S., Mandal, A., Palva, T. E., and Welin, B. (2000)
Improved tolerance to salinity and low temperature in transgenic tobacco producing
glycine betaine. J. Exp. Bot. 51, 177-85.

(18)

Deshnium, P., Gombos, Z., Nishiyama, Y., and Murata, N. (1997) The action in vivo of
glycine betaine in enhancement of tolerance of Synechococcus sp. strain PCC 7942 to
low temperature. J. Bacteriol. 179, 339-44.

(19)

Deshnium, P., Los, D. A., Hayashi, H., Mustardy, L., and Murata, N. (1995)
Transformation of Synechococcus with a gene for choline oxidase enhances tolerance to
salt stress. Plant. Mol. Biol. 29, 897-907.

62
(20)

Fan, F., and Gadda, G. (2005) On the catalytic mechanism of choline oxidase. J. Am.
Chem. Soc. 127, 2067-2074.

(21)

Fan, F., and Gadda, G. (2005) Oxygen- and temperature-dependent kinetic isotope effects
in choline oxidase: correlating reversible hydride transfer with environmentally enhanced
tunneling. J. Am. Chem. Soc. 127, 17954-61.

(22)

Gadda, G. (2003) pH and deuterium kinetic isotope effects studies on the oxidation of
choline to betaine-aldehyde catalyzed by choline oxidase. Biochim. Biophys. Acta. 1650,
4-9.

(23)

Ghanem, M., Fan, F., Francis, K., and Gadda, G. (2003) Spectroscopic and kinetic
properties of recombinant choline oxidase from Arthrobacter globiformis. Biochemistry
42, 15179-15188.

(24)

Gadda, G., Powell, N. L., and Menon, P. (2004) The trimethylammonium headgroup of
choline is a major determinant for substrate binding and specificity in choline oxidase.
Arch. Biochem. Biophys. 430, 264-73.

(25)

Ghanem, M., and Gadda, G. (2005) On the catalytic role of the conserved active site
residue His466 of choline oxidase. Biochemistry 44, 893-904.

(26)

Ghanem, M., and Gadda, G. (2006) Effects of reversing the protein positive charge in the
proximity of the flavin N(1) locus of choline oxidase. Biochemistry 45, 3437-47.

(27)

Allison, D. R., and Purich, D. L. (1979) Practical considerations in the design of initial
velocity enzyme rate assays, in Methods Enzymol. (Purich, D. L., Ed.) pp 3-19, Academic
Press, New York.

(28)

Wormall, A. (1930) The immunological specificity of chemically altered proteins:
Halogenated and nitrated proteins. J. Exp. Med. 51, 295-317.

(29)

Sokolovsky, M., Harell, D., and Riordan, J. F. (1969) Reaction of tetranitromethane with
sulfhydryl groups in proteins. Biochemistry 8, 4740-5.

(30)

Sokolovsky, M., Riordan, J. F., and Vallee, B. L. (1966) Tetranitromethane. A reagent for
the nitration of tyrosyl residues in proteins. Biochemistry 5, 3582-9.

63
(31)

Paech, C., Salach, J. I., and Singer, T. P. (1980) Suicide inactivation of monoamine
oxidase by trans-phenylcyclopropylamine. J Biol Chem 255, 2700-4.

(32)

Patek, D. R., and Hellerman, L. (1974) Mitochondrial monoamine oxidase. Mechanism
of inhibition by phenylhydrazine and by aralkylhydrazines. Role of enzymatic oxidation.
J. Biol. Chem. 249, 2373-80.

(33)

Nagy, J., Kenney, W. C., and Singer, T. P. (1979) The reaction of phenylhydrazine with
trimethylamine dehydrogenase and with free flavins. J. Biol. Chem. 254, 2684-8.

(34)

Mitchell, D. J., Nikolic, D., Jang, M. H., van Breemen, R. B., Hille, R., and Silverman, R.
B. (2001) Inactivation of C30A trimethylamine dehydrogenase by N-cyclopropyl-alphamethylbenzylamine, 1-phenylcyclopropylamine, and phenylhydrazine. Biochemistry 40,
8523-30.

64

Chapter IV
CHEMICAL MODIFICATION OF CHOLINE OXIDASE WITH PHENYLHYDRAZINE

Abstract

The four electron-oxidation of choline to glycine betaine was catalyzed choline oxidase
through two flavin-dependent hydride-transfer steps within the same active site. When choline
oxidase was incubated with phenylhydrazine in 20 mM Tris-Cl at pH 8 and 20 oC, there was an
irreversible loss of enzymatic activity. The inactivation of choline oxidase by phenylhydrazine
was both time and concentration dependent with a second-order rate constant of 0.04 mM-1 min1

. The enzyme was fully protected from inactivation when there was a ligand in the enzyme

active

site,

indicating

the

inactivation

by

phenylhydrazine

is

active-site

directed.

Phenylhydrazine could be use as a substrate of choline oxidase, but substrate-inhibition
mechanism was observed at concentration ≥20 mM.

The inactivation of the enzyme by

phenylhydrazine associated with the bleaching of the 454 nm peak and an increase in absorbance
at 370 nm, suggesting the formation of flavin semiquinone.

However, the percentage of

remaining residual activity was 3 times lower than the remaining oxidized enzyme; therefore, the
generation of flavin semiquinone is not fully responsible for enzyme inactivation. The tryptic
maps of protected and unprotected enzyme samples were compared, but no specific modification
site was identified due to nonselective reactivity of phenylhydrazine.
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Introduction

Choline oxidase (CHO; E.C. 1.1.3.17) from Arthrobacter globiformis was first purified
by Ikuta et. al. in 1977 (1). The enzyme is a homodimer with a mass of 120 kDa that catalyzes
the oxidation of choline to glycine betaine through two flavin-linked sequential hydride transfers
with betaine aldehyde as the intermediate and molecular oxygen as the final electron acceptor
(Scheme 4.1).

(CH3)3N+
Choline

OH

H2O2
(CH3)3N+
O2

Betaine aldehyde

O

H2O2
(CH3)3N+
H2O, O2

O
O

Betaine

Scheme 4.1. Reaction catalyzed by choline oxidase.

The study of choline oxidase is of interest to the understanding of glycine betaine biosynthesis in
pathogenic bacteria (2-11) and transgenic plants (12-17) as a response dehydration and salt stress
in adverse hyperosmotic environments (18, 19). The detail biosynthesis mechanism of glycine
betaine can be used in the research for therapeutic agents that target the inhibition of glycine
betaine biosynthesis and for the engineering of drought resistance in economically relevant
crops.
In the past decade, the biotechnological and medical applications of choline oxidase have
been studied extensively, but there was no reported study on the catalytic mechanism of the
enzyme. Until just recently, we have reported the cloning and expression of the gene coding for
choline oxidase from A. globiformis strain ATCC 8010 in E. coli (20).

With the excess

availability of the enzyme, a number of kinetics and mechanistic studies have been carried out in
our laboratory. The chemical mechanism for the oxidation of choline was understood based on
data from kinetic isotope effects, which suggested the quantum mechanical transfer of a hydride
from the substrate α-carbon to the enzyme-bound flavin cofactor occurring from an activated
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alkoxide form of choline (21, 22). The pH and kinetic isotope effects on the kinetic parameters
kcat and kcat/Km with choline as substrate gave evidence to the participation of active site base
with pKa of ~7.5 in catalysis (23, 24). The roles of His466 in the active site of choline oxidase
were also established by substituting it with an alanine or an asparatate (25, 26). Based on
spectroscopic and kinetic properties of H466A and H466D mutants, His466 is believed to be
responsible for the stabilization of the negative charges on the alkoxide species of choline and on
the N(1)-C(2)=O region of the flavin and contributed into the polarity of the active site of choline
oxidase.
Even though we have gained insights into the catalytic mechanism of choline oxidase
with kinetic and mechanistic techniques, the understanding of detailed catalytic strategy of this
enzyme is still limited at structural level. In the absence of X-ray crystallographic data, chemical
modification with irreversible inhibitors can be used to identify essential residue in the active site
of the enzyme. In this study, phenylhydrazine was used to inactivate the enzyme. The kinetic
and mechanistic data from the inactivation were determined using spectrophotometric and
chromatographic techniques. Identification of the modification site that responsible for the
inactivation of the enzyme were performed using tryptic digestion, HPLC, and mass
spectrometry.
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Experimental Procedures
Materials and enzyme preparations. Choline chloride was from ICN Pharmaceutical

(Aurora, OH). Glycine betaine and phenylhydrazine were from Sigma-Aldrich (St. Louis, MO).
TPCK-treated trypsin was purchased from Worthington (Lakewood, NJ). Recombinant choline
oxidase from Arthrobacter globiformis strain ATCC 8010 was expressed from plasmid
pET/codA1 and purified to homogeneity as described previously (20). Fully oxidized choline
oxidase was prepared as described in ref. (27), and was stored at -20 oC in either 20 mM Tris-Cl,
pH 8, or 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6. The enzyme was
rapidly thawed on ice prior of each experiment. The concentration of choline oxidase was
determined spectrophotometrically at 454 nm using the previously reported ε454 value of 11.4
mM-1cm-1 (24). All kinetic parameters determined were expressed per active site oxidized flavin
content (24). All other reagents were of the highest purity commercially available.
Instruments. Inactivation of enzyme was carried out by incubating the enzyme with the

inhibitor in Eppendorf Mastercycler model 5333 thermostated at 20 oC. Enzyme activity was
measured polarographically by monitoring the rate of oxygen consumption with a Hansatech
oxygen electrode (HansaTech Oxy-32) thermostated at 25 oC. UV-visible absorbance spectra
were recorded on a Hewlett-Packard 8453A diode array spectrophotometer. Purification of
peptides was carried out by HPLC using a Shimadzu instrument equipped with a model SPDM10A photodiode array detector and a µBondapak C18 (15 × 4.6 mm) reverse-phase column.
Enzyme assays. Enzyme activity was measured with the method of the initial rates (28)

in air-saturated 50 mM potassium phosphate at pH 7 by monitoring the rate of oxygen
consumption with a computer-interfaced Oxy-32 oxygen-monitoring system

(Hansatech

Instrument Ltd.) thermostated at 25 oC. The reactions were started by the addition of choline
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oxidase to a 1 ml reaction mixture. Unless otherwise stated, the final concentration of enzyme in
the reaction mixture was in 0.1 to 0.5 µM range, and the concentration of choline was 10 mM.
The enzyme was inactivated by incubating in 20 mM Tris-Cl at pH 8 and 20 oC in the presence
of phenylhydrazine. At different times, aliquots were withdrawn and assayed polarographically
for enzymatic activity. Stock solution of phenylhydrazine was prepared just prior to use.
Tryptic Digestion. To identify the modified site by mechanism-based inhibitor that

resulted in enzyme inactivation, the enzyme was incubated with phenylhydrazine in 20 mM TrisCl at pH 8 and 20 oC in the presence and absence of 140 mM glycine betaine. Enzyme activity
was monitored over time until ~90% of the enzyme became inactivated. Gel filtration was used
to remove the excess reagents.

The inactive enzyme was denatured with 10% (w/v)

trichloroacetic acid and incubated on ice for 30 min before centrifugation at 12000g for 20 min.
The pellets were washed with 10% trichloroacetic acid followed by an ice-cold acetone/HCl
(39:1) mixture, resuspended in 0.1 mL of 8 M urea, 4 mM CaCl2, and 0.4 M ammonium
bicarbonate, pH 8, and allowed to stand for 1 h at 37

C. The solutions were then diluted with

0.3 mL of water before the addition of trypsin to a final concentration of 3% (w/w,
trypsin/choline oxidase). After 4 h incubation at 37

C, a second aliquot of trypsin (1% w/w

final concentration) was added, and the mixture was allowed to react for a further 15 h at 37

C.

The digestion was stopped with trifluoroacetic acid (1% final concentration). Purification of
peptides was carried out by HPLC using a Shimadzu instrument equipped with a model SPDM10A photodiode array detector and a µBondapak C18 (15 × 4.6 mm) reverse-phase column at
a flow rate of 1 mL min-1. Eluent A was 0.05% aqueous trifluoroacetic acid, and eluent B was
0.04% trifluoroacetic acid in acetonitrile. The chromatography was carried out with a linear
gradient from 5% to 50% eluent B over 90 min. Peptide fragments were collected manually. For
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the identification of the modified peptide, MALDI-TOF mass spectrometry was used in both the
positive and negative ion mode with 50:50 methanol/acetonitrile matrix.
Data Analysis. Data were fit with KaleidaGraph software (Synergy Software, Reading,

PA). The steady state kinetic parameters were determined by fitting the data to the MichaelisMenten equation for one substrate. Time course of inactivation of choline oxidase was fit with
eq (1), where A represents the residual activity at a given time (t), A0 is the initial activity, and
kobs is the observed rate of the inactivation. Substrate inhibition data was fit to eq (2) (29), where
v is the velocity of enzyme activity at any concentration S, Vmax′ is the observed maximal
velocity, [S] is the concentration of the substrate, Km′ is the apparent Michaelis-Menten constant,
and KI is the dissociating constant of the inhibitor from the enzyme.
A = A0 e − kobst
v=

Vmax ' [S]
K m' + [S] + K I [S] 2

(1)
(2)
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Results
Inactivation of Choline Oxidase with Phenylhydrazine. When choline oxidase was

incubated with phenylhydrazine in 20 mM Tris-Cl at pH 8 and 20 oC, a time-dependent loss of
enzymatic activity was observed (Figure 4.1 panel A). In the presence of glycine betaine, the
enzyme remained ~100% active with 0.5 mM phenylhydrazine, suggesting that the enzyme is
protected from inactivation in the presence of its catalytic product. As shown in Figure 4.1 panel
B, the inactivation followed second-order kinetics that is dependent on the concentration of
phenylhydrazine and yields a kinact value of 0.04 mM-1 min-1. After inactivated enzyme was
isolated by gel filtration and was incubated in 20 mM Tris-Cl at pH 8 and 20 oC for three hours,
no recovery of activity was observed. This indicated that the inactivation of choline oxidase by
phenylhydrazine was irreversible. Phenylhydrazine was also tested as a substrate for choline
oxidase in 50 mM potassium phosphate at pH 7 and 25 oC. Significant activity was detected
with phenylhydrazine concentrations in the range from 5 mM to 40 mM. The activity of the
enzyme increased with increasing phenylhydrazine concentration up to 20 mM then gradually
decreased at concentrations >20 mM, suggesting a substrate inhibition mechanism (29). The
data were fit with Equation 2 to yield a kcat of 1.1 ± 0.8 s-1, a Km’ of 34.7 ± 27.8 mM, and a KI of
8.5 ± 7.2 mM. The large error obtained from the fitting may due to not enough data points to
define the curve.
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Figure 4.1. Time-dependent inactivation of choline oxidase by phenylhydrazine. Choline
oxidase at 0.54 µM was incubated with different concentrations of phenylhydrazine in 20 mM
Tris-Cl, pH 8, at 20 oC. Enzyme activity was monitored overtime in 50 mM potassium
phosphate, pH 7, at 25 oC. (A) Time course inactivation with phenylhydrazine at (●) 0.5 mM in
the presence of 1.2 M glycine betaine, (○) 0.1 mM, (■) 0.3 mM, (□) 0.5 mM, (♦) 0.9 mM, (◊) 1.2
mM, and (▲) 2.0 mM. (B) The observed rate of enzyme inactivation as a function of the
concentration of phenylhydrazine.
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Figure 4.2. Substrate inhibition behavior of choline oxidase with phenylhydrazine as substrate.
Enzyme activity was measured in 50 mM potassium phosphate, pH 7, at 25 oC. The curve is a fit
of the data to equation (2).
Properties of Choline Oxidase Modified with Phenylhydrazine. UV-visible absorbance

spectrophotometer was used to observe the effect of phenylhydrazine under aerobic conditions
on the flavin cofactor of choline oxidase in 20 mM Tris-Cl at pH 8 and 15 oC. As shown in
panel A of Figure 4.3, the inactivation of the enzyme by phenylhydrazine was associated with
the bleaching of the 454 nm peak and an increase in absorbance at 370 nm, suggesting the
formation of flavin semiquinone. After 2.5 h of incubation, 86% of residual activity was lost and
67% of oxidized flavin was turned into flavin semiquinone (Figure 4.3 panel B). The reduced
form of the enzyme-bound flavin could not be obtained with longer incubation time (up to 30 h)
or with higher concentrations of phenylhydrazine (up to 2 mM).
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Figure 4.3. UV-visible absorbance spectra of the inactivation of choline oxidase at 35.2 µM
with 0.5 mM phenylhydrazine in 20 mM Tris-Cl, pH 8, at 15 oC. (A) For clarity, only selected
UV-visible absorbance spectra were showed; spectra 1 and 10 were recorded at 1 and 150 min of
incubation, respectively. (B) Residual activity (●) and absorbance at 455 nm (○); the data were
fit with equation (1).
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Identification of the Site of Modification of Choline Oxidase by Phenylhydrazine. To

identify the site of modification by phenylhydrazine that is responsible for the inactivation of
choline oxidase, the enzyme was inactivated to 20% residual activity. Excess phenylhydrazine
was removed by gel filtration. The sample was digested with trypsin into peptide fragments.
The peptides were separated by reverse-phase HPLC and compared to the peptides fragment of
another enzyme sample that was treated with the same concentration of phenylhydrazine but was
protected by glycine betaine (Figure 4.4). The two chromatographic maps were similar to each
other except for the peptides eluted at 44.3 min, 50.9 min, and 60.7 min, which showed a
significant difference in peak intensity. These peptides were collected and identified using mass
spectrometry (Table 4.1). The results from mass spectrometry showed that the peptide fragments
eluted at the three elution times were found in both protected and unprotected enzyme sample,
suggesting no specific modification on the peptides. However, at 50.9 min, the unprotected
sample had one extra peak that could not be identified because its mass did not match with any
of the possible modified or unmodified tryptic digested peptides.

Table 4.1. Mass spectrometry analysis of modified peptides in choline oxidase.a
Elution time, min
44.3
50.9

In the presence (+GB) or in the absence
(-GB) of glycine betaine
Molecular weight of peptide from mass
spectrometry analysis, m/z

+GB

-GB

+GB

-GB

60.7
+GB

-GB

1828.8 1828.6 1837.8 1838.6 3208.0 3207.7
1921.8 1921.6
1860.5
2193.0 2191.7
a
Data obtained with MALDI-TOF mass spectrometry, using both positive and negative ion
mode with 50:50 methanol/acetonitrile matrix.
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Figure 4.4. Overlaid HPLC chromatograms of tryptic digests of choline oxidase treated with phenylhydrazine in the presence (black
line) and absence (green line) of glycine betaine. Peptide elution was monitored at 214 nm with a photodiode array spectrophotometer
detector. The peptides eluting at 44.3 min, 50.9 min, and 60.7 min (*) showed a significant difference in peak intensity.
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Discussion

The flavoprotein choline oxidase from Arthrobacter globiformis catalyzes the two steps
oxidation of a primary alcohol substrate to carboxylate product with an aldehyde intermediate.
In the absence of crystallographic data, chemical modification was employed in order to identify
the essential catalytic residues in the active site of choline oxidase.

In this study,

phenylhydrazine was chosen for the modification study of choline oxidase because it can
inactivate the enzyme at low concentrations.

The inhibitory mechanism of enzymes by

phenylhydrazine has also been studied by other authors and understood for other flavoenzymes,
such as monoamine oxidase (30) and trimethylamine dehydrogenase (31) Enzyme inactivation
by phenylhydrazine usually involves the generation of a carbon-centered radical or anion at the
active site (31, 32). These species are highly unstable and could react with the cofactors or
active site residues in the enzyme.
The results presented herein show that the inactivation of choline oxidase by
phenylhydrazine is both time and concentration dependent. The evidence for this conclusion
comes from the single exponential decay of enzymatic activity in the presence of
phenylhydrazine. The observed rate of inactivation also increased with increasing concentration
of phenylhydrazine yielding a second-order rate constant, suggesting a reversible inactivation.
However, there was no recovery of activity when the inactive enzyme was isolated and incubated
at 20 oC for 3 h.

A likely explanation for these results is that the concentrations of

phenylhydrazine used to obtain kobs of inactivation are still bellow KI value (the dissociation
constant of the mechanism-based inhibitor) i. e., larger concentration of phenylhydrazine is
required to reach kinact.

However, reaching kinact can be difficult to achieve because the
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observed rate of inactivation of the enzyme with phenylhydrazine >2.0 mM will be too fast to
measure.
The inactivation of choline oxidase is active-site directed, as suggested by the protective
effect of glycine betaine on the enzyme.

This conclusion is consistent with the fact that

phenylhydrazine can be used as the substrate of choline oxidase. These data implied that the
inactivation of choline oxidase with phenylhydrazine is mechanism-based; the inhibitor is
required be converted into its reactive form for the inactivation to occur. However, more data
are needed to support this interpretation because it is predicted that the flavin peak will be
bleached reversibly by phenylhydrazine under anaerobic conditions if there is an oxidative
process of the inhibitor involved, as previously reported for the case with the flavin-dependent
monoamine oxidase (33).
The formation of flavin semiquinone upon incubation with phenylhydrazine is not fully
responsible for the inactivation of choline oxidase, as suggested by the difference in the
remaining enzymatic activity and the oxidized form of the enzyme3 after 2.5 h incubation with
phenylhydrazine. This is consistent with the involvement of one electron transfer of the flavin in
the process of enzyme inactivation.

To our knowledge, there was no previously reported

electron-transfer inhibitory mechanism observed for the case of flavoenzyme with
phenylhydrazine as the inhibitor.

Instead, phenylhydrazine was well known for inhibition

involving the generation of the phenyl radical, whose reactivity is nonselective (34). In fact, it is

Earlier study by our group reported the semiquinone form of choline oxidase is insensitive to
both oxygen and organic substrate, as suggested by the lack of oxygen consumption and the lack
of change in UV-visible absorbance of the flavin semiquinone in the presence of choline (24).
Therefore, if the semiquinone formation is fully responsible for the inactivation of choline
oxidase with phenylhydrazine, the remaining enzymatic activity at the end of incubation should
be comparable to the amount of oxidized enzyme remained. That is because the oxidized and
unmodified-enzyme was the only species that can consume oxygen in the activity assay.

3
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very likely that the inactivation process of choline oxidase with phenylhydrazine involving both
one electron-transfer of the flavin and the nonselective reaction of phenyl radicals with group(s)
in the active site of the enzyme that participate in catalysis. This hypothesis can also be used to
explain the various modification sites found on tryptic map of the inactive enzyme.
Nevertheless, more data must be obtained in order to prove this hypothesis.
We concluded that the chemical modification of choline oxidase using phenylhydrazine
resulted in nonspecific modification; accounting for the fact of many modifications was found
but no modification site that responsible for enzyme inactivation was identified. However,
modification with higher concentration of phenylhydrazine might be used to reduce the
interaction time of the inhibitor with the enzyme environment, resulting in more selective
modification. Future studies will aim to obtain a more selective modification of choline oxidase
using phenylhydrazine. The identification of a residue that is of importance to the catalytic
mechanism of choline oxidase could be used in future mutagenesis to better understand the
catalytic strategy of the enzyme.

79
References

(1)

Ikuta, S., Imamura, S., Misaki, H., and Horiuti, Y. (1977) Purification and
characterization of choline oxidase from Arthrobacter globiformis. J. Biochem. (Tokyo)
82, 1741-9.

(2)

Bae, J. H., Anderson, S. H., and Miller, K. J. (1993) Identification of a high-affinity
glycine betaine transport system in Staphylococcus aureus. Appl. Environ. Microbiol. 59,
2734-6.

(3)

Culham, D. E., Emmerson, K. S., Lasby, B., Mamelak, D., Steer, B. A., Gyles, C. L.,
Villarejo, M., and Wood, J. M. (1994) Genes encoding osmoregulatory proline/glycine
betaine transporters and the proline catabolic system are present and expressed in diverse
clinical Escherichia coli isolates. Can. J. Microbiol. 40, 397-402.

(4)

Graham, J. E., and Wilkinson, B. J. (1992) Staphylococcus aureus osmoregulation: roles
for choline, glycine betaine, proline, and taurine. J. Bacteriol. 174, 2711-6.

(5)

Kaenjak, A., Graham, J. E., and Wilkinson, B. J. (1993) Choline transport activity in
Staphylococcus aureus induced by osmotic stress and low phosphate concentrations. J.
Bacteriol. 175, 2400-6.

(6)

Kunin, C. M., and Rudy, J. (1991) Effect of NaCl-induced osmotic stress on intracellular
concentrations of glycine betaine and potassium in Escherichia coli, Enterococcus
faecalis, and staphylococci. J. Lab. Clin. Med. 118, 217-24.

(7)

Le Rudulier, D., Bernard, T., Goas, G., and Hamelin, J. (1984) Osmoregulation in
Klebsiella pneumoniae: enhancement of anaerobic growth and nitrogen fixation under
stress by proline betaine, gamma- butyrobetaine, and other related compounds. Can. J.
Microbiol. 30, 299-305.

(8)

Le Rudulier, D., and Bouillard, L. (1983) Glycine betaine, an osmotic effector in
Klebsiella pneumoniae and other members of the Enterobacteriaceae. Appl. Environ.
Microbiol. 46, 152-9.

(9)

Pichereau, V., Bourot, S., Flahaut, S., Blanco, C., Auffray, Y., and Bernard, T. (1999)
The osmoprotectant glycine betaine inhibits salt-induced cross- tolerance towards lethal
treatment in Enterococcus faecalis. Microbiology 145, 427-35.

80
(10)

Pourkomailian, B., and Booth, I. R. (1992) Glycine betaine transport by Staphylococcus
aureus: evidence for two transport systems and for their possible roles in osmoregulation.
J. Gen. Microbiol. 138, 2515-8.

(11)

Peddie, B. A., Wong-She, J., Randall, K., Lever, M., and Chambers, S. T. (1998)
Osmoprotective properties and accumulation of betaine analogues by Staphylococcus
aureus. FEMS Microbiol. Lett. 160, 25-30.

(12)

Sakamoto, A., Alia, Murata, N., and Murata, A. (1998) Metabolic engineering of rice
leading to biosynthesis of glycinebetaine and tolerance to salt and cold. Plant Mol. Biol.
38, 1011-9.

(13)

Sakamoto, A., Valverde, R., Alia, Chen, T. H., and Murata, N. (2000) Transformation of
Arabidopsis with the codA gene for choline oxidase enhances freezing tolerance of
plants. Plant J. 22, 449-53.

(14)

Alia, Kondo, Y., Sakamoto, A., Nonaka, H., Hayashi, H., Saradhi, P. P., Chen, T. H., and
Murata, N. (1999) Enhanced tolerance to light stress of transgenic Arabidopsis plants that
express the codA gene for a bacterial choline oxidase. Plant Mol. Biol. 40, 279-88.

(15)

Holmström, K. O., Somersalo, S., Mandal, A., Palva, T. E., and Welin, B. (2000)
Improved tolerance to salinity and low temperature in transgenic tobacco producing
glycine betaine. J. Exp. Bot. 51, 177-85.

(16)

Deshnium, P., Gombos, Z., Nishiyama, Y., and Murata, N. (1997) The action in vivo of
glycine betaine in enhancement of tolerance of Synechococcus sp. strain PCC 7942 to
low temperature. J. Bacteriol. 179, 339-44.

(17)

Deshnium, P., Los, D. A., Hayashi, H., Mustardy, L., and Murata, N. (1995)
Transformation of Synechococcus with a gene for choline oxidase enhances tolerance to
salt stress. Plant. Mol. Biol. 29, 897-907.

(18)

McNeil, S. D., Nuccio, M. L., and Hanson, A. D. (1999) Betaines and related
osmoprotectants. Targets for metabolic engineering of stress resistance. Plant Physiol.
120, 945-50.

(19)

Burg, M. B., Kwon, E. D., and Kultz, D. (1997) Regulation of gene expression by
hypertonicity. Annu. Rev. Physiol. 59, 437-55.

81
(20)

Fan, F., Ghanem, M., and Gadda, G. (2004) Cloning, sequence analysis, and purification
of choline oxidase from Arthrobacter globiformis: a bacterial enzyme involved in
osmotic stress tolerance. Arch. Biochem. Biophys. 421, 149-158.

(21)

Fan, F., and Gadda, G. (2005) On the catalytic mechanism of choline oxidase. J. Am.
Chem. Soc. 127, 2067-2074.

(22)

Fan, F., and Gadda, G. (2005) Oxygen- and temperature-dependent kinetic isotope effects
in choline oxidase: correlating reversible hydride transfer with environmentally enhanced
tunneling. J. Am. Chem. Soc. 127, 17954-61.

(23)

Gadda, G. (2003) pH and deuterium kinetic isotope effects studies on the oxidation of
choline to betaine-aldehyde catalyzed by choline oxidase. Biochim. Biophys. Acta. 1650,
4-9.

(24)

Ghanem, M., Fan, F., Francis, K., and Gadda, G. (2003) Spectroscopic and kinetic
properties of recombinant choline oxidase from Arthrobacter globiformis. Biochemistry
42, 15179-15188.

(25)

Ghanem, M., and Gadda, G. (2005) On the catalytic role of the conserved active site
residue His466 of choline oxidase. Biochemistry 44, 893-904.

(26)

Ghanem, M., and Gadda, G. (2006) Effects of reversing the protein positive charge in the
proximity of the flavin N(1) locus of choline oxidase. Biochemistry 45, 3437-47.

(27)

Gadda, G., Powell, N. L., and Menon, P. (2004) The trimethylammonium headgroup of
choline is a major determinant for substrate binding and specificity in choline oxidase.
Arch. Biochem. Biophys. 430, 264-73.

(28)

Allison, D. R., and Purich, D. L. (1979) Practical considerations in the design of initial
velocity enzyme rate assays, in Methods Enzymol. (Purich, D. L., Ed.) pp 3-19, Academic
Press, New York.

(29)

Uhr, M. L., Thompson, V. W., and Cleland, W. W. (1973) The kinetics of pig heart
triphosphopyridine nucleotide-isocitrate dehydrogenase. I. Initial velocity, substrate and
product inhibition, and isotope exchange studies. J. Biol. Chem. 249, 2920-7.

82
(30)

Patek, D. R., and Hellerman, L. (1974) Mitochondrial monoamine oxidase. Mechanism
of inhibition by phenylhydrazine and by aralkylhydrazines. Role of enzymatic oxidation.
J. Biol. Chem. 249, 2373-80.

(31)

Nagy, J., Kenney, W. C., and Singer, T. P. (1979) The reaction of phenylhydrazine with
trimethylamine dehydrogenase and with free flavins. J. Biol. Chem. 254, 2684-8.

(32)

Ortiz de Montellano, P. R., and Kerr, D. E. (1983) Inactivation of catalase by
phenylhydrazine. Formation of a stable aryl-iron heme complex. J. Biol. Chem. 258,
10558-63.

(33)

Green, A. L. (1964) Studies on the mechanism of inhibition of monoamine oxidase by
hydrazine derivatives. Biochem. Pharmacol. 13, 249-61.

(34)

Fitzpatrick, P. F., and Villafranca, J. J. (1986) The mechanism of inactivation of
dopamine β-hydroxylase by hydrazines. J. Biol. Chem. 261, 4510-8.

83
Chapter V
CHEMICAL MODIFICATION OF CHOLINE OXIDASE WITH
TETRANITROMETHANE

Abstract

Choline oxidase catalyzes the two sequential flavin-linked hydride transfers that convert
choline to glycine betaine. In this study, the enzyme was irreversibly inactivated with
tetranitromethane in 20 mM Tris-Cl at pH 8 and 20 oC. The inactivation by tetranitromethane
was both time and concentration dependent.

The rate of inactivation followed saturation

kinetics, yielding a first-order rate constant (kinact) of 0.32 ± 0.01 h-1, and a dissociation constant
(KI) of 0.66 ± 0.04 mM, suggesting the inactivation occurred after tetranitromethane bound to the
enzyme. The product of the enzyme catalytic reaction, glycine betaine, protected the enzyme
from inactivation, indicating the inactivation is active-site directed. UV-visible absorbance of
both protected and unprotected enzyme sample showed the presence of nitrated tyrosines, but the
unprotected sample had greater absorbance intensity equivalent to a difference of 5 tyrosines.
The tryptic maps of protected and unprotected enzyme sample were compared, but the
modifications by tetranitromethane were found on both enzyme samples; therefore, no specific
modification site was identified.
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Introduction

Tetranitromethane (TNM) has been used in chemical modification of many proteins since
1930 (1). In many cases, incubation with this reagent resulted in the irreversible inactivation of
the enzyme. The inactivation may be active-site-directed, as shown by the protective effects of
competitive inhibitors. Detailed studies of on the protein modification by tetranitromethane have
suggested that the reaction of TNM involves the nitration of tyrosyl residues (2, 3). The reaction
of tetranitromethane with tyrosyl residue involve the formation of a charge-transfer complex
with the phenol group of the tyrosine, followed by the generation of the phenoxide and nitrite
radicals due to electron transfer. The nitrite radicals reacts with the phenoxide and results in the
formation of the nitrotyrosine and the release of a nitroformate anion. Additional reactions are
possible due to the high reactivity of phenolate radicals with each other.
Choline oxidase is a flavin-dependent enzyme with a dimeric structure and a mass of 120
kDa (4). The enzyme has gained attention from research field because of its almost unique
catalytic strategy, which allowed the oxidation of an alcohol and an aldehyde to occur in the
same active site. The detail catalytic reaction of choline oxidase is illustrated in Scheme 5.1,
which involves the oxidation of choline to glycine betaine through two oxidation steps with
betaine aldehyde as the intermediate and molecular oxygen as the final electron acceptor
(Scheme 5.1).

(CH3)3N+
Choline

OH

H2O2
(CH3)3N+
O2

Betaine aldehyde

O

H2O2
(CH3)3N+
H2O, O2

O
O

Betaine

Scheme 5.1. Reaction catalyzed by choline oxidase.

Other than the interesting catalytic mechanism, choline oxidase was considered of importance to
both medical and biotechnological applications because the product of its catalytic reaction,
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glycine betaine. Glycine betaine is a compatible solute that can be found to accumulated by (5,
6) human pathogens (7-16) and crop plants (17-22) as a response to dehydration and plasmolysis
in the environments. For these reasons, the study of choline oxidase can give insights into
glycine betaine biosynthesis found in bacterial and plants, enabling the development of drug that
can target the resistance of human pathogens to the environments on host tissue and for the
engineering of transgenic plants that carried drought and salt stress resistance.
Over the years, our group have reported a number studies on choline oxidase. Firs, the
cloning and expression of the gene coding for choline oxidase from A. globiformis strain ATCC
8010 in E. coli was carried out successfully (4). Kinetic isotope effect was used to elucidate the
chemical mechanism for the oxidation of choline catalyzed by choline oxidase (23, 24). The
results suggested that the hydride transfer between the α-carbon of the activated alkoxide form
of choline and the enzyme-bound flavin cofactor occurred quantum mechanically. The presence
of an active site base with pKa of ~7.5 was also established based on the data from pH and
kinetic isotope effects of the kinetic parameters of choline oxidase with choline as substrate (2527). The roles of His466 was characterized when the histidine was replaced with and alanine or
an asparatate. Spectroscopic and kinetic properties of H466A and H466D mutants suggested that
His466 stabilized in the negative charges in the enzyme active site by its imidazolium side chain
and contributed into the polarity of the microenvironment of the flavin (28, 29).
Despite the in depth understanding on the catalytic mechanism of choline oxidase based
kinetic and mechanistic studies, our investigation on this enzyme is still limited without 3dimensional structure.

Consequently, chemical modification of choline oxidase using

tetranitromethane was used in this study to identify the tyrosine residue that may be essential for
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catalysis.

Kinetic and structural properties of the inactivation of choline oxidase by

tetranitromethane were characterized using spectrophotometric and chromatographic techniques.
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Experimental Procedures
Materials and enzyme preparations. Choline chloride was from ICN Pharmaceutical

(Aurora, OH). Glycine betaine and tetranitromethane were from Sigma-Aldrich (St. Louis, MO).
TPCK-treated trypsin was purchased from Worthington (Lakewood, NJ). Recombinant choline
oxidase from Arthrobacter globiformis strain ATCC 8010 was expressed from plasmid
pET/codA1 and purified to homogeneity as described previously (4). Fully oxidized choline
oxidase was prepared as described in ref. (27), and was stored at -20 oC in either 20 mM Tris-Cl,
pH 8, or 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6. The enzyme was
rapidly thawed on ice prior of each experiment. The concentration of choline oxidase was
determined spectrophotometrically at 454 nm using the previously reported ε454 value of 11.4
mM-1cm-1 (26). All kinetic parameters determined were expressed per active site oxidized flavin
content (26). All other reagents were of the highest purity commercially available.
Instruments. Inactivation of enzyme was carried out by incubating the enzyme with the

inhibitor in Eppendorf Mastercycler model 5333 thermostated at 20 oC. Enzyme activity was
measured polarographically by monitoring the rate of oxygen consumption with a Hansatech
oxygen electrode (HansaTech Oxy-32) thermostated at 25 oC. UV-visible absorbance spectra
were recorded on a Hewlett-Packard 8453A diode array spectrophotometer. Purification of
peptides was carried out by HPLC using a Shimadzu instrument equipped with a model SPDM10A photodiode array detector and a µBondapak C18 (15 × 4.6 mm) reverse-phase column.
Enzyme assays. Enzyme activity was measured with the method of the initial rates (30)

in air-saturated 50 mM potassium phosphate at pH 7 by monitoring the rate of oxygen
consumption with a computer-interfaced Oxy-32 oxygen-monitoring system

(Hansatech

Instrument Ltd.) thermostated at 25 oC. The reactions were started by the addition of choline
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oxidase to a 1 ml reaction mixture. Unless otherwise stated, the final concentration of enzyme in
the reaction mixture was in 0.1 to 0.5 µM range, and the concentration of choline was 10 mM.
The enzyme was inactivated by incubating in the presence of tetranitromethane in 20 mM TrisCl at pH 8 and 20 oC. At different times, aliquots were withdrawn and assayed polarographically
for enzymatic activity. Stock solution of tetranitromethane was prepared in ethanol prior use.
Tryptic Digestion.

The enzyme was first incubated with tetranitromethane in the

presence and absence of 140 mM glycine betaine until there was ~10% of residual activity left in
the unprotected sample. The enzyme was isolated from excess TNM by gel filtration. The
inactive enzyme was denatured with 10% (w/v) trichloroacetic acid and incubated on ice for 30
min before centrifugation at 12000g for 20 min. The pellets were washed with 10%
trichloroacetic acid followed by an ice-cold acetone/HCl (39:1) mixture, resuspended in 0.1 mL
of 8 M urea, 4 mM CaCl2, and 0.4 M ammonium bicarbonate, pH 8, and allowed to stand for 1 h
at 37

C. The solutions were then diluted with 0.3 mL of water before the addition of trypsin to

a final concentration of 3% (w/w, trypsin/choline oxidase). After 4 h incubation at 37

C, a

second aliquot of trypsin (1% w/w final concentration) was added, and the mixture was allowed
to react for a further 15 h at 37

C. The digestion was stopped with trifluoroacetic acid (1% final

concentration). Purification of peptides was carried out by HPLC using a Shimadzu instrument
equipped with a model SPD-M10A photodiode array detector and a µBondapak C18 (15 × 4.6
mm) reverse-phase column at a flow rate of 1 mL min-1. Eluent A was 0.05% aqueous
trifluoroacetic acid, and eluent B was 0.04% trifluoroacetic acid in acetonitrile. The
chromatography was carried out with a linear gradient from 5% to 50% eluent B over 90 min.
Peptide fragments were collected manually.

MALDI-TOF mass spectrometry in both the
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positive and negative ion mode with 50:50 methanol/acetonitrile matrix was used to identify the
modified peptide.
Data Analysis. Data were fit with KaleidaGraph software (Synergy Software, Reading,

PA). The steady state kinetic parameters were determined by fitting the data to the MichaelisMenten equation for one substrate. Time course of inactivation of choline oxidase was fit with
eq (1), where A represents the residual activity at a given time (t), A0 is the initial activity, and
kobs is the observed rate of the inactivation. The rates of inactivation of the enzyme were fit to eq
(2), where kinact is the first-order rate constant for the conversion of the reversibly formed
enzyme-inhibitor complex to irreversibly inactivated enzyme, [I] is the concentration of the
mechanism-based inhibitor, and KI is the dissociation constant of the mechanism-based inhibitor
from the enzyme.
A = A0 e − kobst
k obs =

k inact [I]
[ I] + K I

(1)
(2)
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Results
Inactivation of Choline Oxidase with Tetranitromethane. When choline oxidase was

incubated with tetranitromethane in 20 mM Tris-Cl at pH 8 and 20 oC, a time-dependent loss of
enzymatic activity was observed (Figure 5.1 panel A). The inactivation was dependent on the
concentration of tetranitromethane. When the observed rates of inactivation were plotted as a
function of the concentration of tetranitromethane (Figure 5.1 panel B), a saturation curve was
observed, suggesting the inactivation followed first-order kinetics that involved reversible
binding of tetranitromethane to the enzyme followed by irreversible inactivation of the enzyme.
The curve was fit with equation 2 to yield a kinact of 0.32 ± 0.01 h-1 and a KI of 0.66 ± 0.04 mM.
In the presence of glycine betaine, the enzyme was fully protected from inactivation at ≤2.5 mM
tetranitromethane, but it was only partially protected at >2.5 mM tetranitromethane, suggesting
that the inactivation might become nonselective at high concentration of tetranitromethane. No
activity recovery was detected when the inactivated enzyme was isolated by gel filtration then
incubated in 20 mM Tris-Cl at pH 8 and 20 oC for 2h. This is consistent with the inactivation
choline oxidase by tetranitromethane being irreversible.

To verify that the presence of

tetranitromethane did not affect the biological function of active choline oxidase, the enzyme
was inactivated to 30% of residual activity then isolated by gel filtration. Activity assay of this
sample yielded a turn over number (kcat) of 7.6 ± 0.1 s-1, which was equivalent to ~30% of the
kcat value of the fully active enzyme, i. e., 18.6 ± 0.6 s-1 (Figure 5.2). The Michaelis-Menten
constant (Km) in partially modified and native enzyme samples were 0.61 ± 0.03 mM and 0.63 ±
0.07 mM, respectively, suggesting that the activity detected was only due to the active form of
the enzyme in the partially modified sample. In this context, the data indicated that the partially
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modified enzyme sample contains a mixture of inactive and active enzymes and that the active
enzyme in the sample was still functioned normally and was capable of catalysis.
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Figure 5.1. Time-dependent inactivation of choline oxidase with tetranitromethane. Choline
oxidase at 0.54 µM was incubated with different concentrations of tetranitromethane in 20 mM
Tris-Cl, pH 8, at 20 oC. Enzyme activity was monitored over time in 50 mM potassium
phosphate, pH 7, at 25 oC. (A) Time course of inactivation at different concentrations of
tetranitromethane. For clarity, only data with (●) 0.5 mM, (○) 1.0 mM, (■) 4 mM, and (□) 5 mM
tetranitromethane are shown. (B) Secondary plot of the observed rate of inactivation as a
function of the concentration of tetranitromethane. The data were fit to equation (2).
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Figure 5.2. Activity assay of native (○) and TNM-modified (●) choline oxidase in 50 mM
potassium phosphate, pH 7, at 25 oC. The TNM-modified enzyme sample was prepared by
incubating the enzyme with 5 mM TNM in 20 mM Tris-Cl, pH 8, at 20 oC. Inactivation of
enzyme was allowed to occur until 35% of residual activity remained, then excess TNM was
removed using gel filtration. The data were fit to Michaelis-Menten equation for one substrate.
Properties of Choline Oxidase upon Inactivation with Tetranitromethane. The TNM-

modified form of choline oxidase in the presence and absence of glycine betaine was isolated
with gel filtration and their UV-visible absorbance spectra were compared (Figure 5.3). Both
spectra showed a significant increase in absorbance at 360 nm as compared to the spectrum of
native enzyme, indicating the presence of nitrotyrosines. However, the TNM-modified sample
in the absence of glycine betaine has spectrum with larger intensity as compared to that of the
enzyme sample that was incubated in the presence of glycine betaine, suggesting a different
amount of modified tyrosine in the enzyme when it was partially protected from inactivation.
The amount of tyrosine residues being modified was quantitated using the absorbance difference
between the TNM-treated enzyme and the native enzyme and ε360 = 14 M-1 cm-1 for the nitrated
tyrosine at 360 nm (2, 31). The result showed that there was a difference of 5 modified tyrosyl
residues in TNM-modified enzyme sample in the absence of glycine betaine as compare to the
TNM-modified sample in the presence of glycine betaine.
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Figure 5.3. UV-visible absorbance spectra of the native form (thin line) and the TNM-modified
forms of choline oxidase in the presence (dotted line) and in the absence (thick line) of glycine
betaine. Both protected and unprotected enzyme samples were incubated with 8 mM
tetranitromethane in 20 mM Tris-Cl at pH 8 and 20 oC.
Identification of the Site of Modification of Choline Oxidase by Tetranitromethane. To

identify the site of modification by tetranitromethane that might be responsible for the
inactivation of choline oxidase, the enzyme was inactivated with tetranitromethane to 24%
residual activity. Excess tetranitromethane was removed by gel filtration. The sample was
digested with trypsin into peptide fragments. The peptides were separated by reverse-phase
HPLC and compared to the peptides of another enzyme sample that was treated with the same
concentration of tetranitromethane but was partially protected by glycine betaine (Figure 5.4).
The two chromatographic maps at 360 nm contained various differences both in peak intensity
and position. The peptides eluting at 31.1 min were collected because the peak at this retention
time showed the most significant difference. Mass spectrometric analysis showed that the same
peptide fragments were found in both protected and unprotected sample (data not shown),
suggesting nitration at these peptides might not be responsible for the inactivation of choline
oxidase by tetranitromethane.
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Figure 5.4. Overlaid HPLC chromatograms of tryptic digests of choline oxidase treated with tetranitromethane in the presence (black
line) and absence (green line) of glycine betaine. Peptide elution was monitored at 360 nm with a photodiode array spectrophotometer
detector. The peak that eluted at 31.1 min (*) was collected for mass spectrometry analysis.
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Discussion

The biosynthesis of glycine betaine by choline oxidase is of importance to both medical
and biotechnological applications because glycine betaine was found to accumulate in beneficial
plants and bacterial as stress resistance to adverse hyperosmotic environments (7-22). Over five
years, detailed studies on kinetics and mechanistic properties of choline oxidase were carried out,
providing a good understanding on the catalytic mechanism of the enzyme. However, in the
absence of crystallographic data, the study on catalytic strategy of choline oxidase at structural
level was limited. An alternate approach using chemical modification was employed in order to
identify essential catalytic residue in the active site of choline oxidase.

In this study,

tetranitromethane was chosen for the modification study of choline oxidase because it can
inactivate the enzyme with significant rate.
The results presented herein show that the inactivation of choline oxidase with
tetranitromethane is both time and concentration dependent. The evidence for this conclusion
comes from the single exponential decay of enzymatic activity in the presence of
tetranitromethane. The observed rate of inactivation increased with increasing concentration of
tetranitromethane to a limiting value. This is consistent with the reversible binding of enzyme
and tetranitromethane occurred before the inactivation of the enzyme.

Evidence for the

inactivation of the enzyme being irreversible was found when the isolated inactive enzyme was
incubated at 20 oC and no activity recovery was observed for 3 h.
The inactivation of choline oxidase is active-site directed with ≤2.5 mM
tetranitromethane but is nonselective with >2.5 mM tetranitromethane, as suggested by the
protective effect of glycine betaine on the enzyme. The increase in intensity of UV-visible
absorbance at 360 nm of the TNM-modified enzyme is the evidence for formation of nitrated
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tyrosine upon inactivation with tetranitromethane. The fact that the nitration of tyrosine was
observed in both protected and unprotected enzyme sample can be explained by the fact that
choline oxidase has 11 tyrosyl residues in its amino acid sequence, so it is likely that tyrosyl
residues outside the active site have been modified. Such modification might be responsible for
the partial inactivation of the enzyme in the presence of a ligand in the active site. This is
consistent with the data from UV-visible absorbance spectra, which showed that the unprotected
enzyme sample has 5 nitrotyrosines more than that found in the protected sample when the
inactivation was carried out with 8 mM tetranitromethane.
Comparison of the tryptic maps of protected and unprotected enzyme sample revealed the
nonspecific modification of tetranitromethane, as suggested by various differences found on the
chromatograph at 360 nm. Since the enzyme was only partially protected at tetranitromethane
>2.5 mM, the results cannot be improved by using high concentration of tetranitromethane.
In conclusion, the chemical modification of choline oxidase using tetranitromethane
resulted in nonselective modification; therefore, no essential peptide can be identified in this
study. Future study will be necessary to obtain a more selective modification of choline oxidase
using different mechanism-based inhibitor. The identification of a residue that is of importance
to the catalytic mechanism of choline oxidase can be used in future mutagenesis to better
understand the catalytic strategy of the enzyme.
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Chapter VI
TRAPPING OF CHOLINE OXIDASE IN A NON-FUNCTIONAL CONFORMATION BY
FREEZING AT LOW PH

(A revised version of this chapter has been submitted for publication in Proteins by Hoang, J. V.
and Gadda, G. on July 2006)
Abstract

Choline oxidase is a flavin-dependent enzyme that catalyzes the oxidation of choline to
glycine-betaine, with oxygen as electron acceptor. Storage at pH 6 and -20 oC resulted in a
change in the conformation of choline oxidase, as suggested by spectroscopic data, which was
associated with compete loss of catalytic activity when the enzyme was assayed at pH 6.
Treatment of the inactive enzyme at pH values ≥6.5 and 25 oC resulted in the fast and partial
reactivation of the enzyme, which occurred within 6 min, resulting in the slow onset of steady
state during enzymatic turnover. The rate of approaching steady state was independent of the
concentrations of choline and enzyme, but increased to a limiting value with increasing pH,
defining a macroscopic pKa value of ~7.3 for an unprotonated group required for enzyme
activation. Prolonged incubation of the inactive enzyme at pH 6 and temperatures ≥20 oC
resulted in the slow and full recovery of activity over 3 hours, associated with a conformational
change that reverted the enzyme to the native form, as suggested by spectrophotometric data.
‡

‡

The temperature-dependence of the slow enzyme activation at pH 6 yielded ∆H and ∆S values
‡

of ~112 kJ mol-1 and ~64 J K-1 mol-1, respectively, resulting in an entropy of activation (T∆S ) at
25 oC of ~20 kJ mol-1. These data suggest that freezing the enzyme at low pH induces a localized
and reversible conformational change that is associated with the complete and reversible loss of
catalytic activity.
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Introduction

For years, freezing has been used extensively for the storage of purified enzymes. In most
cases, isolated soluble enzymes stored at sub-freezing temperatures and neutral or slightly
alkaline pH values are found to be stable and maintain catalytic activity, although in some cases
partial loss of catalytic activity due to the unfolding of the protein may arise during the freezing
and thawing processes. In a limited number of cases, however, subjecting purified enzymes to
storage at sub-freezing temperatures results in the reversible loss of catalytic activity not being
associated with unfolding of the protein, as exemplified by L-amino acid oxidase, phosvitin, and
glutamate mutase (1-8). In this context, significant deviations of the pH from neutrality in the
storage buffer have been shown to contribute to inactivation, due to changes either in the
quaternary structure of the protein or in the ionization of groups that participate in catalysis (9).
For the documented cases of ovoperoxidase, phosphofructokinase, leucocyte proteinase 3, and
formyltetrahydofolate synthetase, such pH effects on the catalytic activity of the enzyme have
been shown to be reversible (9-12). A common manifestation of the reversibility of the
inactivation process is a slow onset of steady state during enzymatic turnover (10, 12). While
such a hysteretic behavior is commonly found in allosteric enzymes as a strategy for metabolic
regulation (13-16), it is not common for other classes of enzymes. During the procedure
employed to purify choline oxidase, the enzyme showed a significant hysteretic behavior after
storing at pH 6 and -20 oC (Fan Fan, Prashanthi Menon, Jane V. Hoang, and Giovanni Gadda;
unpublished observations), a step used to fully oxidize the enzyme-bound flavin4 (18),
suggesting that the enzyme might be affected by freezing at low pH.

4

The enzyme-bound flavin in choline oxidase as purified is present as a mixture of oxidized
and anionic flavosemiquinone (17). The fully oxidized enzyme is commonly prepared by
extensive dialysis at pH 6 and 4 oC over 24 hours, as reported in ref. (18), or by short dialysis at
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Choline oxidase (E.C. 1.1.3.17) catalyzes the flavin-mediated two-step oxidation of
choline to glycine betaine, with betaine aldehyde as intermediate and molecular oxygen as
electron acceptor (Fig. 1) (19-21). The enzyme is of both biotechnological and medical interest
since glycine betaine can be accumulated in the cytoplasm of cells to prevent dehydration and
plasmolysis in adverse hyperosmotic environments (22, 23) in pathogenic bacteria (24-33) and
transgenic plants (34-39). Consequently, the study of choline oxidase has potential for the
development of therapeutic agents targeted at the inhibition of glycine betaine biosynthesis and
for the engineering of drought resistance in economically relevant crops. Furthermore, choline
oxidase has been extensively used for the development of biosensors to detect choline and
choline ester derivatives, such as acetylcholine, in serological fluids and foodstuff (40-44). The
enzyme is a homodimer of 120 kDa, with each monomer containing covalently bound FAD (17).
The chemical mechanism for the oxidation of choline catalyzed by choline oxidase has been
recently elucidated using kinetic isotope effects, and is consistent with the quantum mechanical
transfer of a hydride from the substrate α-carbon to the enzyme-bound flavin cofactor occurring
from an activated alkoxide form of choline (45, 46). Such an alkoxide species has been proposed
to form by the action of an active site base with pKa of ~7.5 (18, 47, 48), and to be
electrostatically stabilized in the enzyme active site by the imidazolium side chain of His466 (49,
50). In the present study, we have investigated the effect of storage temperature and pH on the
biophysical and catalytic properties of choline oxidase. The results of these studies suggest that
freezing the enzyme at low pH induces a localized and reversible conformational change that is
associated with the complete and reversible loss of enzymatic activity.

pH 6 and 4 oC over 3 to 5 hours, followed by storage at pH 6 and -20 oC (Fan Fan, Prashanthi
Menon, Jane V. Hoang, and Giovanni Gadda; unpublished observations).
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Experimental Procedures
Materials and enzyme preparations. Choline chloride was from ICN Pharmaceutical

(Aurora, OH). Glycine betaine was from Sigma-Aldrich (St. Louis, MO). Recombinant choline
oxidase from Arthrobacter globiformis strain ATCC 8010 was expressed from plasmid
pET/codA1 and purified to homogeneity as described previously (17). Fully oxidized choline
oxidase was prepared as described in ref. (18), and was stored at -20 oC in either 20 mM Tris-Cl,
pH 8, or 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6. The enzyme was
rapidly thawed on ice prior of each experiment. When needed, buffers were changed either by
gel filtration through disposable PD-10 desalting columns (Amersham Pharmacia Biotech,
Piscataway, NJ) or dialysis for 19 h at 4 oC. The concentration of choline oxidase was
determined spectrophotometrically at 454 nm using the previously reported ε454 value of 11.4
mM-1cm-1 (48). All kinetic parameters determined were expressed per active site oxidized flavin
content (48). All other reagents were of the highest purity commercially available.
Instruments.

UV-visible absorbance spectra were recorded using an Agilent

Technologies diode-array spectrophotometer Model HP 8453; fluorescence spectra were
acquired on a Shimadzu spectrofluorometer model RF-5301; circular dichroic spectra were
determined using a Jasco J-180 spectropolarimeter. Time-courses of oxygen consumption were
determined polarographically with an oxygen electrode from Hansatech Instruments Ltd.
(Norfolk, UK).
Spectral studies.

Absorbance, fluorescence, and circular dichroic spectra were

determined in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6, at 15 oC. The
concentration of enzyme in flavin content was: 11 µM for the UV-visible absorbance spectra, 3
µM for the protein fluorescence emission spectra (with λex at 285 nm), 11 µM for the flavin
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fluorescence emission (with λex at ~455 nm), and 2.5 µM, 50 µM, and 168 µM for the CD
spectra of the protein in the far-UV, near-UV, and visible regions of the spectra, respectively.
Enzyme assays.

Unless otherwise stated, time-courses of oxygen consumption and

enzymatic activity were determined polarographically by measuring the rate of oxygen
consumption using a computer-interfaced oxygen electrode system in air-saturated 50 mM
potassium phosphate, at pH 7 and 25 oC. The determination of the kinetic parameters of choline
oxidase was carried out using the method of the initial rates (51), with concentrations of choline
in the range from 0.1 to 10 mM. For the determinations at pH 8 and 9, 50 mM sodium
pyrophosphate was used as buffer. For the enzyme species showing slow onsets of steady state
during turnover, rates of oxygen consumptions were determined from the linear portions of the
traces, i.e., after steady state was achieved.
Effect of pH on hysteresis. For the determination of the pH effects on the fast rate of

reactivation of choline oxidase (kc), the activity of the enzyme species with hysteretic behavior
was measured in 50 mM Tris (hydroxymethyl) aminomethane with the pH in a range from 6.5 to
9.6 at 25 oC.
Effect of temperature on reactivation of choline oxidase at pH 6. The temperature

effects on the slow rate of activation of choline oxidase (kact) were determined by incubating the
inactive enzyme in the range from 20 to 39 oC at pH 6, and the activity was measured in 50 mM
morpholinoethansulfonic acid, at pH 6 and 25 oC.
Data analysis. Data were fit with KaleidaGraph software (Biosoft, Cambridge, UK). The

steady state kinetic parameters were determined by fitting the data to the Michaelis-Menten
equation for one substrate. The first-order rate constants for the fast and pH-dependent activation
of the inactive form of choline oxidase (kc) were determined by fitting the time-courses of
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oxygen consumption to eq 1, which was modified from Frieden (16), where vf represents the
observed rate of reaction after reaching steady state, and [O2]o is the initial concentration of
oxygen. The pH dependence of kc was determined by using eq 2, which describes a curve with a
slope of +1 and a plateau region at high pH where C represents the pH-independent value. The
apparent rates of activation of the enzyme at any given temperature were determined by fitting
the observed rates of oxygen consumption at any given incubation time with eq 3 that describes a
single exponential process. Here,

app

kact is the apparent first-order rate constant for the

temperature-dependent slow activation of the inactive form of choline oxidase, t is time, At is the
value of enzymatic activity, Ao is the amplitude of the total change, and A∞ is the enzymatic
activity at infinite time. The temperature dependence of kact was determined by using the Eyring's
equation (eq 4), where kact is the first-order rate constant for enzyme activation, kB and h are the
Boltzmann and Planck constants, T is the absolute temperature in Kelvin, R is the gas constant
‡

‡

with a value of 8.315 J mol-1 K-1, and ∆H and ∆S are the enthalpy and entropy of activation,
respectively.
1 − e − kc t
∆[O 2 ] t = vf t − vf
+ [O 2 ]o
kc

(1)

⎛
⎜
C
log k c = log⎜
⎜
10 −pH
1
+
⎜
⎝ 10 −pKa

(2)

At = A∞ − Ao e − t

app

⎞
⎟
⎟
⎟
⎟
⎠

k act

‡
∆H ‡
⎛k ⎞
⎛ k ⎞ ∆S
−
ln⎜ act ⎟ = ln⎜ B ⎟ +
R
RT
⎝ h ⎠
⎝ T ⎠

(3)
(4)
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Results
Effect of storage pH and temperature on the enzymatic activity of choline oxidase.

Storage of the enzyme at pH 6 and -20 oC resulted in a choline oxidase form that was devoid of
enzymatic activity at pH 6 and 25 oC, as suggested by the lack of oxygen consumption over
extended incubation of the enzyme with 1 mM choline in 50 mM potassium phosphate, pH 6. In
contrast, this enzyme form slowly regained enzymatic activity with 1 mM choline at pH 7 and 25
o

C, with a significant hysteretic behavior that was apparent as a slow onset of steady state during

enzymatic turnover (Figure 6.1).
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Figure 6.1. Time-courses of oxygen consumption during turnover of choline oxidase at a final
concentration of 0.54 µM with 1 mM choline as substrate in air-saturated 50 mM potassium
phosphate, pH 7, at 25 oC. Solid curve represents the trace using choline oxidase previously
stored at pH 8 and -20 oC; dashed curve is the trace using choline oxidase previously stored at
pH 6 and -20 oC. E indicates the time at which the enzyme was added to the assay reaction
mixture. Thin lines represent the tangents to the linear portions of the trace obtained with choline
oxidase previously stored at pH 6 and -20 oC.

Significant lags in catalytic turnover were also observed when the enzyme was flash-frozen in a
mixture of dry ice and acetone at pH 6. In contrast, no lag in the time-courses of oxygen
consumption was observed when the enzyme was stored at pH 6 and 0 oC or at pH 8, irrespective
of whether the storage temperature was -20 oC or 0 oC. Similarly, no hysteretic behavior was
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seen when the enzyme was stored at pH 6 and -20 oC or -80 oC in the presence of 30 or 50%
glycerol as anti-freezing agent, or when choline oxidase was kept on ice for as long as 26 h.
These data suggest that freezing of choline oxidase at low pH results in a form of enzyme with
altered catalytic properties (E').
To evaluate whether the presence of a ligand in the active site of the enzyme affected the
formation of E', choline oxidase was frozen at pH 6 in the presence of 0.14 M glycine betaine,
which resulted in ~90% of the enzyme being in a glycine betaine-complex at this pH (48, 50).
The time-courses of oxygen consumption of the enzyme stored in the presence of glycine betaine
showed hysteretic behavior (data not shown), suggesting that the altered E' form of choline
oxidase could be formed irrespective of whether the enzyme was in the free or liganded form.
Kinetic parameters of choline oxidase stored at pH 6 and -20 oC. The turnover number

(kcat) and the Michaelis-Menten constant (Km) for choline as substrate for the enzyme previously
stored at pH 6 and -20 oC were determined in 50 mM potassium phosphate, at pH 7 and 25 oC,
and were compared to those determined for the enzyme that did not show hysteretic behavior
(E), which was prepared in three different ways by storing choline oxidase at pH 6 or 8 and 0 oC,
or at pH 8 and -20 oC. As shown in Table 6.1, E' showed a kcat value that was 3-times lower than
the value determined for E, and a Km value that was similar to that determined for E. Kinetically,
these data suggest that the altered form of choline oxidase prepared by freezing at pH 6 was
devoid of enzymatic activity, and that upon reaching steady state at pH 7 and 25 oC the enzyme
existed as a mixture of the fully active form E that is responsible for the consumption of oxygen
(~30%) and the inactive form E'. Similar results with kcat values that were ~30% of the value
determined for the native enzyme and Km values that were similar to those of the native enzyme
were observed with the altered form of choline oxidase at pH 8 and 9 (data not shown),
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suggesting that only 30% of the inactive enzyme could regain activity within the time required
for the oxygen electrode recordings (3 to 6 min).

Table 6.1. Kinetic parameters of choline oxidase stored at pH 6 and -20 oC with choline as
substrate at pH 7 and 25 oC. a
storage pH
storage temperature, oC
kcat, s-1
Km, mM
L b, s

6

-20

4.4 ± 0.1

0.7 ± 0.1

30 – 70

6

0

13.3 ± 0.2

0.5 ± 0.1

nd c

8

0

14.9 ± 0.2

0.6 ± 0.1

nd

8

-20

15.5 ± 0.1

0.6 ± 0.1

nd

a

The enzymatic activity of choline oxidase that was previously stored at the pH and temperature
indicated was measured at varying concentrations of choline in air-saturated 50 mM potassium
phosphate, pH 7, at 25 oC.
b
L represents the length of the lag phase observed before the rate of oxygen consumption reached
steady state.
c
nd, not detectable.

Effect of choline and enzyme concentrations on hysteresis. The effect of choline

concentration on the hysteretic behavior of choline oxidase under turnover was determined with
the E' form of enzyme at a final concentration of 0.54 µM, in air-saturated 50 mM potassium
phosphate, pH 7 and 25 oC. Fitting of the time-courses of oxygen consumption obtained with
choline concentrations in the 0.5 to 8 mM range by using eq 1 yielded first-order rate constants
for the attainment of steady state (kc) that were independent of choline concentration (Table 6.2),
with an average value of 0.017 ± 0.001 s-1. In contrast, the time required to reach steady state,
i.e., lag time, decreased with increasing concentrations of choline and reached a limiting value of
~30 s, consistent with the apparent length of the lag phase in catalysis being inversely dependent
on substrate concentration (Table 6.2).
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The effect of enzyme concentrations in the range from 1.1 to 2.8 µM on the hysteretic
behavior of choline oxidase was also determined with 1 mM choline as substrate at pH 7 and 25
o

C. As summarized in Table 6.2, the kc values were similar to each other and, most importantly,

were not significantly different from the average kc value determined at varying concentrations
of choline. As for the case of choline, the apparent length of the lag phase in catalysis was
inversely dependent on the enzyme concentration, with shorter lags seen at increasing
concentrations of choline oxidase. Finally, no differences in the length of the lag phase preceding
steady state were observed in the time-courses of oxygen consumption in assay reaction mixtures
at pH 7 and 25 oC containing KCl at concentrations as high as 180 mM (data not shown),
suggesting that the activation of the E' form of choline oxidase did not depend on the ionic
strength of the solvent.
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Table 6.2. Effect of enzyme and substrate concentrations on hysteresis at pH 7
and 25 oC. a
E', µM
[choline], mM Lb, s vfc, µM s-1
kcc, s-1
R2

a

0.54

0.5

54

0.83 ± 0.01

0.015 ± 0.001

0.9997

0.54

2.0

42

1.30 ± 0.01

0.015 ± 0.001

0.9995

0.54

4.0

42

1.40 ± 0.01

0.018 ± 0.001

0.9999

0.54

6.0

36

1.65 ± 0.01

0.016 ± 0.001

0.9997

0.54

8.0

30

1.40 ± 0.01

0.016 ± 0.001

0.9998

1.10

1.0

48

1.28 ± 0.01

0.013 ± 0.001

0.9996

1.66

1.0

42

1.88 ± 0.01

0.012 ± 0.001

0.9994

2.20

1.0

36

1.93 ± 0.01

0.015 ± 0.001

0.9994

2.76

1.0

30

2.23 ± 0.01

0.016 ± 0.001

0.9993

Time-courses of oxygen consumption during turnover of choline oxidase
previously stored frozen at pH 6 at the final concentrations indicated (E') with
choline in 20 mM Tris-Cl, pH 7 and 25 oC, were fit to eq 1.
b
L is the lag in catalytic turnover, i.e., the time required to the enzyme to reach
steady state conditions.
c
vf represents the observed rate of reaction after reaching steady state; kc is the
first-order rate constant for approaching steady state.
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Effect of pH on hysteresis. The effect of pH on the hysteretic behavior of choline

oxidase was determined in the range from 6.5 to 9.6 at fixed concentrations of choline as
substrate for choline oxidase and 25 oC. The substrate concentration was set equal to the Km
value at each pH, in order to avoid artifactual contributions arising from the dependence of the
length of the lag phase that precedes steady state on the concentration of choline5. The kc values
were determined at each pH value by fitting the time-courses of oxygen consumption to eq 1.
The log kc value increased to a limiting value with increasing pH, yielding a pKa value of 7.3 ±
0.1 for a group that must be unprotonated for activation of the enzyme (Figure 6.2).
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Figure 6.2. pH dependence of the first-order rate constant for approaching steady state (kc) of
choline oxidase previously stored at pH 6 and -20 oC. Enzymatic activity was determined with
choline at concentrations set equal to the Km values with 0.54 µM enzyme in 50 mM potassium
phosphate at 25 oC. kc values were determined by fitting the time-courses of oxygen consumption
to eq 1. The curve is a fit of the data to eq 2.
Spectral properties of choline oxidase stored at pH 6 and -20 oC. In order to evaluate

whether protein structural changes were associated with the different catalytic behavior of
choline oxidase upon freezing at pH 6, the CD, absorbance, and fluorescence properties of E'

5

Choline concentrations that were equal to Km were chosen, instead of saturating
concentrations, because at high pH and saturating concentrations of choline as substrate for the
enzyme the lengths of the lag phases were too short in order to obtain accurate data.
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were determined at pH 6 and 15 oC and compared to those of E. As shown in Figure 6.3A, the
far-UV CD spectra of E' and E were virtually indistinguishable, consistent with both forms of
choline oxidase being folded with similar contents in secondary structure elements. However, the
UV-visible absorbance spectrum of E' showed a 9 nm hypsochromic shift of the peak centered at
366 nm and a 4 nm bathochromic shift of the band at 457 nm, both associated with significant
decreases in intensities, with respect to the absorbance spectrum of E (Figure 6.3B). Both the
protein and flavin fluorescence emission bands at ~340 nm and ~525 nm were two- to threetimes more intense in the spectra of E' compared to E (Figure 6.3C-D). Furthermore, a
significant bathochromic shift in the near-UV CD spectrum of E' was observed in the 270 to 290
nm region of the spectrum with respect to that of E (Figure 6.3E). Finally, an inversion of the
polarity in the visible dichroic band in the 450 nm region of the CD spectrum of the enzymebound flavin was observed upon comparing the visible CD spectra of E' and E, as shown in
Figure 6.4F. These data suggest that upon freezing the enzyme at low pH, choline oxidase
undergoes a change in its conformation that significantly affects the flavin microenvironment.
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Figure 6.3. Determination of the apparent rate of activation of choline oxidase previously stored
at pH 6 and -20 oC. The E' form of choline oxidase was incubated in 20 mM sodium phosphate,
20 mM sodium pyrophosphate, pH 6 and 25 oC, over 160 min. At different time intervals,
aliquots of the enzyme solution were assayed for enzymatic activity with 1 mM choline as
substrate in 50 mM 2-morpholinoethanesulfonic acid, pH 6 and 25 oC. Panel A, selected timecourses of oxygen consumption, where curves 1 and 6 represent the traces acquired after 2 and
72 min of incubation. Panel B, plot of the enzymatic activity as a function of incubation time for
the determination of the first-order apparent rate constant for activation of choline oxidase by
using eq 3.
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Effect of temperature on activation of the E' form of choline oxidase at pH 6. The

effect of temperature on the rate of activation of choline oxidase previously stored at pH 6 and 20 oC was determined at pH 6 with 1 mM choline as substrate. At this pH value, the first-order
rate constant for the fast conversion of E' to E (kc) was expected to be sufficiently slow (Figure
6.2) to affect minimally the time-course of oxygen consumption, thereby simplifying the analysis
of the data. As expected, the time-courses of oxygen consumption did not show any lag before
enzyme turnover reached steady state (Figure 6.4A). Moreover, as illustrated in the example of
Figure 6.4 for the data at 25 oC, the rates of oxygen consumption increased to a limiting value
that was similar to the value of ~5 s-1 obtained with 1 mM choline as substrate for the native
enzyme with increasing time of incubation of the enzyme, yielding apparent rates for the slow
temperature-dependent activation of the enzyme (appkact) at any given temperature (Table 6.3).
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Figure 6.4. Temperature dependence of the first-order rate constant for activation of choline
oxidase (kact) in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, at pH 6. The data
were fit to eq 4.

116

Table 6.3. Effect of temperature on the rate of reactivation of choline oxidase at pH 6.a

temperature, oC

a

app

kact x 1,000 b, s-1

kden x 1,000 c, s-1

kact x 1,000 d, s-1

20

0.17 ± 0.01

0.04 ± 0.01

0.21 ± 0.01

25

0.47 ± 0.02

0.08 ± 0.01

0.55 ± 0.02

30

1.03 ± 0.11

0.04 ± 0.01

1.07 ± 0.11

33

1.87 ± 0.40

0.11 ± 0.01

1.98 ± 0.41

35

1.40 ± 0.22

0.28 ± 0.03

1.68 ± 0.22

37

2.50 ± 0.39

0.40 ± 0.06

2.90 ± 0.39

39

3.61 ± 1.17

0.53 ± 0.06

4.14 ± 1.17

Enzymatic activity was determined with 1 mM of choline and 0.54 µM of enzyme in 50 mM
air-saturated 2-morpholinoethanesulfonic acid, pH 6, at 25 oC.
b
Measured rate of enzyme activation upon incubation of the E' form of enzyme at the indicated
temperature.
c
Observed rate of activity loss upon incubation of the fully active enzyme at the indicated
temperature.
d
True rate of enzyme activation, obtained by adding the rate of activity loss kden to the measured
rate of enzyme activation, appkact. The standard deviation for each of the kact values was calculated
from the square root of the sum of the squares of the standard deviations associated with kden and
app
kact.
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The contribution of enzyme denaturation ensuing from the prolonged incubations at high
temperatures was taken into account by measuring the first-order rate constant for the loss of the
enzymatic activity (kden) of the fully active E form of choline oxidase (Table 6.3). These values
were then added to the

app

kact values in order to determine the true first-order rate constants for

the activation of the E' form of choline oxidase in the temperature range from 20 to 39 oC (Table
‡

6.3). An analysis of the kact value according to the Eyring's formalism yielded a ∆H value of 112
‡

± 7 kJ mol-1 and a ∆S value of 64 ± 7 J K-1 mol-1 (Figure 6.5). These data are consistent with a
‡

‡

T∆S value of 19 ± 2 kJ mol-1 and a ∆G value of ~93 kJ mol-1 for the activation barrier for the
conversion of E' to E at 25 oC. Such a small entropic contribution is consistent with the
conformational change that is associated with the activation of the enzyme being localized rather
than global.

-12
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-10

-14
-16
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(1/T) * 1000, K
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Figure 6.5. Temperature dependence of the first-order rate constant for activation of choline
oxidase (kact) in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, at pH 6. The data
were fit to eq 4.

As shown in Figure 6.6, incubation of the E' form of choline oxidase at pH 6 and 25 oC
resulted in changes in the UV-visible absorbance spectrum of the enzyme, which slowly
converted to that of the native form of choline oxidase. From the increase in absorbance at 385
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nm associated with this process, an apparent first-order rate for the conversion of E' to E of (3.3
± 0.3) x 10-4 s-1 was determined (Figure 6.6inset). The spectrophotometric changes observed
suggest that the enzymatic activation of the altered form of choline oxidase is associated with a
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∆ε, mM cm
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change in the conformation of the enzyme.
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Figure 6.6. Conversion of the E' form to E form of choline oxidase. The E' form of choline
oxidase was incubated in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, at pH 6 and
25 oC, and UV-visible absorbance spectra were recorded over 180 min. Only selected spectra at
different times of incubation minus the initial spectrum of the E´ form are shown; 1 and 6 refer to
the difference spectra at 12 and 180 min of incubation. Inset, time-course of absorbance increase
at 385 nm. Data were fit to eq 3.
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Discussion

Choline oxidase is reversibly inactivated by freezing at pH 6. Evidence supporting this
conclusion comes from the lack of oxygen consumption when the enzyme previously stored at
pH 6 and -20 oC was assayed with choline as substrate at pH 6 and 25 oC. Upon raising the pH of
the assay reaction mixture to values ≥6.5 the enzyme was slowly reactivated, as shown by the
appearance of a detectable lag in the establishment of steady state during turnover with choline.
Similar lags were also observed upon flash-freezing choline oxidase at pH 6 and -80 oC. In
contrast, no lags in the time-course of oxygen consumption were observed upon storing the
enzyme at pH 6 on ice or at sub-freezing temperatures in the presence of the anti-freezing agent
glycerol. Furthermore, storage of the enzyme at pH 8 did not produce the altered catalytic
behavior, irrespective of whether the temperature was 0 oC or -20 oC, indicating that inactivation
of the enzyme results from the synergistic action of sub-freezing temperature and low pH.
Similar effects of freezing on the catalytic activity of enzymes have been previously reported for
a limited number of cases, such as L-amino acid oxidase (1, 5-8), glutamate mutase (4), and
phosvitin (2).
From a biophysical standpoint, treatment of the enzyme at pH 6 and -20 oC induces a
change in the conformation of choline oxidase, which is associated with the loss of catalytic
activity. Evidence supporting a conformational change of the enzyme comes from the UV-visible
absorbance, protein and flavin fluorescence emission, and near-UV and flavin circular dichroic
spectra of choline oxidase after storage at -20 oC and pH 6, all showing significant differences
with respect to the spectra of the enzyme stored at pH 8. In this respect, the altered conformation
of the enzyme is not due to denaturation of the protein, since the far-UV circular dichroic
spectroscopic analysis showed that the altered form of choline oxidase (E') maintains an overall
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fold similar to that of the native enzyme. The circular dichroic spectrum of the flavin bound to
the E' form of choline oxidase independently suggests that the enzyme is not denatured, since no
circular dichroic features are expected for a flavin once it is extracted from the protein
microenvironment (52). Mechanistically, the molecular motions that are required for the change
in the conformation of choline oxidase might occur in the rigidity of the ice lattice, for which
movements of photons, electrons, and protons for molecular reactions in frozen systems have
been previously established (53-56). Alternatively, the change in the conformation of choline
oxidase might occur during the freezing process in which the ice crystals are in the process of
being formed (55-57), as previously proposed for phosvitin (2). Irrespective of whether the
conformational change occurs in the frozen state or during the freezing process, such a structural
change results in a conformation of choline oxidase that is not catalytically competent, as
suggested by the lack of oxygen consumption with choline as substrate at pH 6 and 25 oC. The
kinetic parameters determined at pH 7 for the partially reactivated enzyme previously frozen at
low pH, with a lower kcat and a similar Km with respect to the native enzyme, provide
independent evidence that E' is devoid of enzymatic activity, since these results are readily
explained with the enzyme during steady state turnover at pH 7 existing as a mixture of fully
active (E) and inactive forms (E').
Treatment of the inactive E' form of choline oxidase at pH values ≥6.5 and 25 oC results
in the pH-dependent reactivation of ~30% of the enzyme, through a first-order kinetic process
that occurs within the time frame of the oxygen electrode recordings (3 to 6 min). Evidence for
this conclusion comes from the observed slow onsets of steady state when the E' form of the
enzyme turned over with choline, as illustrated in the example of Figure 6.1. Consistent with
reactivation of the enzyme being a first-order process, the apparent rate constant for reaching
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steady state kc was independent of the concentrations of both the enzyme and the choline
substrate6. Furthermore, the kcat and Km values determined at pH 7, 8, and 9, for the enzyme
previously frozen at pH 6 clearly suggest that only ~30% of the inactive enzyme could be
reactivated within minutes through this pH-dependent process. A protein group with an apparent
pKa of ~7.3 that must be unprotonated is involved in the activation of the altered form of choline
oxidase, as suggested by the pH-profile of the first-order rate constant kc for reaching steady state
during enzyme turnover. The slow pH-dependent reactivation of the inactive form of choline
oxidase, along with the requirement of sub-freezing temperatures and low pH for the inactivation
of the enzyme, strongly suggest that the reversible loss of enzymatic activity is due to the
incorrect ionization of one or more protein groups that are not readily accessible to the solvent.
In this respect, inactivation of the enzyme occurs irrespective of whether the enzyme is in the
free form or in complex with glycine betaine, consistent with the ionizable group(s) responsible
for the loss of catalytic activity not being in the active site of the enzyme. Similar reversible
inactivations of enzymes being due to the incorrect ionization of protein groups have been
previously proposed for ovoperoxidase (10), phosphofructose kinase (11), formyltetrahydrofolate
synthetase (9), and leukocyte proteinase 3 (12).
The spectral perturbations induced in the UV-visible absorbance spectrum of choline
oxidase upon freezing at low pH, with a prominent decrease in the intensity at 385 nm with
respect to the native enzyme, resembled, although they were not identical to, those observed
upon increasing pH with both the native and the active site variant His466Ala of the enzyme (49).
6

The length of the lag time required to reach steady state during enzymatic turnover of the
altered choline oxidase was inversely proportional to the concentrations of both choline and
enzyme. This is due to the rate of oxygen consumption at sub-saturating concentrations of
choline increasing with both [choline] and [enzyme], and the rate constant for reaching steady
state (kc) being a first-order rate constant that is independent of both [choline] and [enzyme].
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The spectral perturbations with those enzymes were interpreted as arising from the deprotonation
of the N(3) locus of the enzyme-bound oxidized flavin (58). However, such a flavin position
must be readily accessible to the solvent, as suggested by the observation that the spectral
perturbations induced by pH in the native enzyme and the His466Ala variant occur rapidly, ruling
out a direct change in the ionization state of FAD as being responsible for the loss of enzymatic
activity in choline oxidase. Nonetheless, the change in ionization state of the group that is
responsible for the loss of enzymatic activity in choline oxidase has a direct effect on the spectral
properties of the flavin, suggesting that such an ionizable group is either close to the flavin or
linked to the flavin through a number of weak interactions, such as hydrogen bonds or salt
bridges. Independent evidence that the conformational change induced in choline oxidase by
freezing at low pH affects the microenvironment of the flavin comes from the both the 4 nm
bathochromic shift of the band at 457 nm and the three-fold increase in flavin fluorescence, both
consistent with an increased hydrophobicity of the flavin microenvironment in the inactive form
of choline oxidase compared to the native enzyme (58).
At pH 6, the reactivation of the inactive form of choline oxidase is too slow to be seen
within the time required for the acquisition of the oxygen traces, as suggested by the kc value of
~3 x 10-3 s-1 estimated from the pH studies. Indeed, at this pH the enzyme did not show any
oxygen consumption with 1 mM choline. However, prolonged incubation over 180 min of the
inactive form of choline oxidase at pH 6 and 25 oC resulted in the slow and complete activation
of the enzyme following a first-order process with a rate constant of activation kact of ~4.7 x 10-4
s-1. Evidence supporting the conclusion that the enzyme was slowly converted to the active form
comes from the rate of oxygen consumption of ~4.5 s-1 with 1 mM choline determined after 180
min of incubation, which was similar to the rate of oxygen consumption of ~5 s-1 observed under
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the same conditions with the native enzyme. The slow activation of choline oxidase was closely
associated with a conformational change that reverted the enzyme to the native form, as
suggested by the UV-visible absorbance spectral changes observed upon incubating the altered
form of choline oxidase at pH 6 and 25 oC. Such spectral changes occurred according to a firstorder kinetic pattern with a rate constant of ~3 x 10-4 s-1, which is in reasonable agreement with
the kact value of ~5 x 10-4 s-1 determined for the rate of enzyme activation under the same
conditions7, consistent with the conformational change being closely associated with the gain in
enzyme activity. Such a change in the conformation of the enzyme is likely localized, as
suggested by the small and positive entropy of activation (T∆S) calculated at 25 oC from the
experimental data, with a value of ~20 kJ mol-1. For comparison, a larger T∆S value of ~90 kJ
mol-1 was estimated at 25 oC for the pH-dependent reactivation of formyltetrahydrofolate
synthetase, which was associated to a large conformational change accompanying the formation
of the active tetramer from the inactive monomers of the enzyme (9).
In conclusion, the kinetic and spectroscopic data presented in this study are consistent
with a localized conformational change in choline oxidase that is associated with the change in
the ionization state of one or more protein groups, which is induced by freezing at low pH. The
slow reactivation of the enzyme required elevated temperatures and was facilitated by high pH,
suggesting that fairly drastic conditions are required to enable the enzyme "locked" in the
inactive conformation to revert to the native form. Although the groups responsible for the
7

The two rates reported here are not rigorously the same. However, some inaccuracies in the
determination of the rate of activity increase for the altered form of enzyme can be envisioned
due to the instability of the enzyme at 25 oC for 180 min. In this respect, the stability of the
altered enzyme was established by following the decrease in activity of the native enzyme under
the same conditions, with the assumption that the native and altered forms of choline oxidase
share the same stability. Since the two forms of enzymes have different conformations, as
established in this study, they might also have slightly different stability.
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change in the protein conformation are not readily accessible to the solvent, and therefore are not
likely to be in the enzyme active site, they have a direct effect on the microenvironment of the
enzyme-bound flavin and the activity of the enzyme. While the basis for this phenomenon and its
relationship to the mechanism of the reaction are not fully understood at a molecular level, this
study shows that localized structural changes trap choline oxidase in a non-functional folded
conformation that has reversibly lost the ability to catalyze the oxidation of choline.
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Chapter VII
GENERAL DISCUSSION

Choline oxidase from Arthrobacter globiformis is one of the rare flavin-dependent
enzymes that are capable of catalyzing the four electron-oxidation of choline to glycine betaine
within the same active site (1-3). Other than the interesting catalytic strategy, the enzyme was
also studied due to its importance to the biotechnological and biomedical research. Early studies
showed that glycine betaine was found to accumulate in the cytoplasm of cells in pathogenic
bacteria (4-13) and transgenic plants (14-19) as a resistance for dehydration and plasmolysis in
adverse hyperosmotic environments (20, 21). The understanding of the catalytic mechanism of
choline oxidase gives insights into the biosynthesis pathway of glycine betaine found in human
pathogens and economically relevant crop plants thereby provides foundations for drug
development that can inhibit the stress resistance of pathogenic bacterial in human tissue or for
bioengineering of transgenic plants with stress resistance to drought and salt stress. In this study,
the chemical modification of choline oxidase with phenylhydrazine or tetranitromethane was
performed with an attempt to identify the residues that are significant to the catalysis. Enzyme
inactivation due to freezing in 20 mM sodium phosphate and 20 mM sodium pyrophosphate at
pH 6 and -20 oC was also investigated as a measure of how storage conditions can affect the
biochemical properties of choline oxidase.
Seven reagents were tested as inhibitors for choline oxidase, including 2-hydrazinoN,N,N-trimethyl-2-oxopethanaminium, allyltrimethylammonium, isonicotinic acid hydrazide, 3dimethylamino-1-propyne,
tetranitromethane.

trans-2-phenylcyclopropylamine,

phenylhydrazine,

and

The choice of reagents stemmed from previous studies, in which these

compounds were reported to inhibit enzymes to significant extend and were successfully used in
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modifying the active site of the enzyme.

The resulted showed that only trans-2-

phenylcyclopropylamine, phenylhydrazine, and tetranitromethane inactivated choline oxidase
significantly in 20 mM Tris-Cl at pH 8 and 20 oC. Trans-2-phenylcyclopropylamine inactivated
the enzyme with observed rates of 0.2-0.3 h-1 at 10-50 mM. This inhibitor may not be useful to
modify the enzyme because large concentrations of inhibitor may cause unwanted alternation of
enzyme structure or unspecific modification. Phenylhydrazine and tetranitromethane are better
choices because they inactivated the enzyme with observed rate of 0.5-4.4 h-1 at 0.1-2.0 mM and
0.1-0.4 h-1 at 0.5-5.0 mM, respectively.
More than one modification sites may be obtained for choline oxidase when
phenylhydrazine was used as the inhibitor, as suggested by kinetic and spectroscopic data from
the chemical modification study.

Phenylhydrazine inactivated choline oxidase irreversibly

because there was no activity recovered when the inactive enzyme was isolated and incubated in
20 mM Tris-Cl at pH 8 and 20 oC. However, when the observed rate of inactivation was plotted
as a function of the concentration of phenylhydrazine, a second-order inactivation rate suggested
a reversible inhibitory process. A likely explanation for these results is that the observed rates of
inactivation were still below the dissociation constant, KI, of choline line oxidase with
phenylhydrazine. The inhibitory mechanism of phenylhydrazine with choline oxidase occurred
in the active site and involved one electron-transfer of the flavin cofactor, as suggested by the
protective effect of glycine betaine and the formation of flavin semiquinone when the enzyme is
incubated with phenylhydrazine at pH 8 and 15 oC in the presence of oxygen. Nevertheless, the
generation of flavin semiquinone was not fully responsible for the inactivation of the enzyme
because the percentage of the enzyme with the flavin semiquinone is not equivalent to the
percentage of activity loss. When tryptic maps of glycine betaine-protected and unprotected
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enzyme sample were compared, it appeared that phenylhydrazine modified enzyme at more than
one site, i.e., more experiments are needed to improve the selectivity of the modification of
essential residues in the active site of choline oxidase.
Choline oxidase can be inactivated when one or more tyosines in the active site of
choline oxidase was modified with a nitro group. The evidence for this conclusion comes from
the chemical modification study of choline oxidase with tetranitromethane.

In that study,

tetranitromethane inactivated choline oxidase irreversibly. The inactivation was both time and
concentrations dependent.

A saturation curve was observed when the observed rates of

inactivation were plotted as a function of tetranitromethane, indicating the inactivation followed
first-order kinetics.

The maximal inactivation rate, kinact, was 0.32 ± 0.01 h-1, and the

dissociation rate constant, KI, was 0.66 ± 0.04 mM. These data suggested a reversible enzymeinhibitor complex and an irreversible inactivation at saturating tetranitromethane concentrations.
This is consistent with the inactivation of the enzyme by tetranitromethane being active-site
directed, as suggested by the protective effect of glycine betaine on choline oxidase. UV-visible
absorbance of both protected and unprotected enzyme sample showed the presence of nitrated
tyrosines, but the unprotected sample had more intensity in absorbance equivalent to a difference
of 5 tyrosines. Although choline oxidase has 11 tyrosines total, it is unlikely that there are 5
tyrosines present in its active site. The tryptic maps of protected and unprotected enzyme sample
were also compared, the results suggested that there were various modification sites and no
specific modification site was identified with mass spectrometry.

More experiments and

troubleshooting need to be performed in order to identify an essential tyrosyl residue, whose
modification might be responsible for enzyme inactivation.
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Choline oxidase can be inactivated due to a displacement of one or more protons and a
localized conformation change in the active site, which can be induced with storage conditions.
This conclusion is supported by the study of enzyme inactivation. In that study, the enzyme was
inactivated after freezing in 20 mM sodium phosphate and 20 mM sodium pyrophosphate at pH
6 and -20 oC, as suggested by the complete loss of catalytic activity of the enzyme. Comparison
of the spectroscopic properties between the inactive and the native forms of the enzyme at pH 6
and 15 oC showed that choline oxidase undergoes a localized conformation change upon freezing
at pH 6 and -20 oC. Treatment at pH ≥6.5 and 25 oC can partially reactivate the enzyme, as
suggested by the slow onset of steady state during enzymatic turnover. The conversion of
inactive to active form of choline oxidase is a first-order rate constant that is independent of
substrate and enzyme concentrations. However, the rate of conversion from inactive to active
enzyme is pH dependent, yielding a pKa value of 7.3 ± 0.1 for a group that needs to be
unprotonated for the activation of the enzyme. The full activation of the enzyme can be observed
spectroscopically at pH 6 and 25 oC in 3 h, with an increasing change in the absorbance at 385
nm. A temperature-dependence study of the enzyme at pH 6 and temperatures ≥20 oC yielded an
∆H‡ of 112 ± 7 kJ mol-1 and an entropy of activation (T∆S‡) at 25 oC of 19 ± 2 kJ mol-1. The data

presented in this part of the study suggested that the inactivation of choline oxidase due to
freezing at pH 6 and -20 oC involves a localized and reversible conformational change that is
associated with a deprotonation of protein groups in the flavin microenvironment.
In summary, the results obtained in this study showed that choline oxidase can be
inactivated by both chemical and physical means.

Phenylhydrazine and tetranitromethane

inactivated the enzyme irreversibly. Both compounds are active-site directed inhibitors. As for
phenylhydrazine, it can be used as substrate for choline oxidase, and the inactivation with this
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compound associated with the formation of flavin semiquinone in the presence of oxygen.
However, the generation of flavin semiquinone is not fully responsible for enzyme inactivation.
As for tetranitromethane, the inactivation associated with the increase in absorbance at 360 nm,
where nitrated tyrosines absorbed. The modification sites in both studies were not identified due
to nonselective reactivity of the compounds on the enzymes. Choline oxidase can also be
inactivated by freezing in 20 mM sodium phosphate and 20 mM sodium pyrophosphate at pH 6
and -20 oC. The inactivation is reversible with pH ≥6.5 and at temperature ≥20 oC. The results
suggested that enzyme reactivation required a group to be unprotonated, and the ionization of
this group induced a localized conformational change that leads to enzyme inactivation. By
studying enzyme inactivation due to chemical and physical means, we have gained insights into
the biochemical properties of choline oxidase, thereby adding useful information onto the
understanding of this enzyme, such as how enzyme function can be affected significantly by the
modification at the active site or the displacement of a proton and a slight conformational change
in the microenvironment of the flavin cofactor. Consequently, the findings reported in this thesis
may provide insights into the importance of the rigorous organization in the active site of choline
oxidase; slight alteration of this organization can result in the complete loss of biological
function of the enzyme.
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